WO2014020226A1 - Additives for feeding aquatic animals, containing probiotics - Google Patents

Additives for feeding aquatic animals, containing probiotics Download PDF

Info

Publication number
WO2014020226A1
WO2014020226A1 PCT/ES2013/070573 ES2013070573W WO2014020226A1 WO 2014020226 A1 WO2014020226 A1 WO 2014020226A1 ES 2013070573 W ES2013070573 W ES 2013070573W WO 2014020226 A1 WO2014020226 A1 WO 2014020226A1
Authority
WO
WIPO (PCT)
Prior art keywords
cect
aquatic animals
amyloliquefaciens
ecobiol
additive
Prior art date
Application number
PCT/ES2013/070573
Other languages
Spanish (es)
French (fr)
Inventor
Enrique PABLOS PÉREZ
Original Assignee
Norel, S.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norel, S.A filed Critical Norel, S.A
Publication of WO2014020226A1 publication Critical patent/WO2014020226A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics

Definitions

  • the present invention discloses additives for feeding aquatic animals, additives containing at least one probiotic which, in addition, may be accompanied by at least one salt of an organic acid. These additives are used as promoters or growth stimulants and enhancers of the animal's health status. Therefore, the present invention is encompassed within the field of aquaculture and more specifically within animal production, food and health.
  • aquatic animals differ from terrestrial animals in the level of interaction between the intestinal microbiota and the surrounding environment.
  • the bacteria present in the aquatic environment influence the composition of the microflora of the intestine of aquatic animals and vice versa.
  • the composition of the bacterial community of the intestinal tract of aquatic animals is different from what is found in terrestrial animals.
  • Gram negative bacteria predominate in the marine environment and Gram positive in a smaller proportion; these usually constitute the majority of the bacteria that normally occur in the microflora associated with wild and cultivated shrimp.
  • the vast majority of microbes present in the marine environment bacteria are harmless or are successfully controlled by the internal defense mechanisms of organisms in culture.
  • probiotics are useful for promoting the health of an animal, they are often difficult to store, handle and administer to these animals, especially when such administration is done by dissolving the additive, along with the usual food of the animals, in The aquatic environment.
  • the food formulation not only has to complete the requirements of the animals, it must also produce a very stable food in the water because the aquatic animals are introduced continuously and continuously.
  • the shrimp detects the food at a distance by chemoreception, so that this food must also be attractive (that attracts the animal) and palatable (that likes the taste), and must also have a uniform shape and composition. In this sense, the use of attractive substances allows food to be located and consumed faster by animals.
  • the present invention describes a new food additive for aquatic animals comprising at least two bacterial strains, preferably in spore form, belonging to the genus Bacillus and selected from among Bacillus amyloliquefaciens and Bacillus cereus.
  • Bacillus amyloliquefaciens CECT 5940 is a bacterial strain isolated by NOREL S.A., Spain deposited on April 25, 2001 in the Spanish Collection of Crops type sita in the Scientific Park of the University of Valencia. Calle Agust ⁇ n Escardino Professor, 9 de Paterna (Valencia) and, which is marketed as the probiotic ECOBIOL.
  • ECOBIOL is a probiotic in the form of resistant spores capable of surviving even the process of granulation and / or pelletization of feed. Once in the animal, where the bacterium finds a suitable medium for its development in terms of temperature and humidity nutrients, the spores that make up the ECOBIOL germinate, then passing the bacteria to produce all the beneficial effects for the animal. Said probiotic is also characterized in that it has a better reproduction ratio compared to other Bacillus spp spores and is also capable of releasing chemical compounds that have an inhibitory effect on the pathogenic population.
  • Bacillus cereus CECT 953 is a bacterial strain isolated by NOREL SA, Spain deposited on October 25, 1988 in the Spanish Collection of Crops type sita in the Science Park of the University of Valencia. Calle Agust ⁇ n Escardino Professor, 9 de Paterna (Valencia) and, which is marketed as the probiotic ESPORAFEED.
  • ESPORAFEED is a probiotic in the form of resistant spores capable of surviving even the process of granulation of feed for animal feed. Said probiotic is characterized by resisting high granulation temperatures, as well as physical and acidifying agents. In addition, ESPORAFEED produces enzymes that improve the digestibility of the diet.
  • the additives described in the present invention are added to the diet of aquatic animals, preferably in those animals farmed by aquaculture and which are selected, among others, from any of the following list: crustaceans, molluscs, tilapia, gilthead sea bass and salmonids.
  • the additive of the invention acts as a natural growth promoter, showing an improvement in the feed conversion factor, an increase in the growth of animals and biomass, as well as an increase in the survival of the animals to which these additives are administered to animals fed without the additive.
  • the additive of the invention may also contain other ingredients capable of strengthening the immune system and improving the digestibility of the food resulting in an increase in the action of probiotics.
  • these ingredients are salts of organic acids, with sodium salt of butyric acid being preferred.
  • Organic short-chain acids are capable of reducing the pH at the intestinal level, which limits the development of pathogens and helps in the digestion of proteins and, on the other hand, they have the ability to enter the bacteria, specifically those pathogens and block their metabolism. Its bactericidal action is exerted preferably between the genera: Escherichia, Campylobacter, Clostridium and Salmonella, among others.
  • the Norel SA Spain product marketed under the name of GUSTOR BP-70 is used, from here and, throughout the entire invention we will call it BP-70.
  • the BP-70 is formed by the sodium salt of protected butyric acid, against early digestion, with a matrix of vegetable fats, which protect only a part of the active ingredient and allow the slow release of the product, thus ensuring its potentiating action growth and bactericide throughout the digestive tract of the animal.
  • This partial protection ensures that a part of the butyrate reaches the farthest parts of the digestive tract of animals, thus exercising its action.
  • unprotected sodium butyrate will exert its action on the nearest parts of the digestive tract.
  • the protected sodium butyrate will exert its action on the most distal parts of the digestive tract, once the protective layer that prevents its action has hydrolyzed throughout the digestive process.
  • the additives described in the present invention further favor the specific activity of digestive enzymes, preferably of lipases, proteases, amylases and chymotrypsins, as well as the food conversion factor, which results in greater use of the food and consequently greater biomass of animals.
  • concentrations of each of the ingredients purchased by the additives of the invention are incorporated in amounts sufficient to achieve the beneficial properties thereof, such as improving the food conversion factor, a better utilization of the food, an increase in its biomass. and an increase in the longevity of individuals.
  • Another object described in the present invention relates to the use of the additives of the invention as promoters of the growth of aquatic animals, as well as promoter of their health and well-being, by providing the additives of the invention to fed animals. with them from a reinforced immune system.
  • the white spot syndrome virus WSSV
  • the white spot syndrome virus is the main pathogen of shrimp and outbreaks kill all shrimp populations in a few days, being by therefore responsible for large production / profit losses in this industry worldwide.
  • the virus has a wide range of hosts, such as crustaceans such as crabs, spiny lobsters, crayfish, etc.
  • the clinical signs of "white spot” include a sudden reduction in food consumption, lethargy, cuticle loss, discoloration and presence of white spots of 0.5 to 2.0 mm in diameter on the inner surface of the shell, appendages and on the cuticle of the abdominal segments.
  • Another object of the present invention relates to a method for promoting the growth of aquatic animals by administering the additive described in the invention, since said additive is capable of giving greater use to the food consumed.
  • aquaculture refers to the set of technical activities and knowledge of cultivation of aquatic plant and animal species. It is an important economic activity of food production, raw materials for industrial and pharmaceutical use, and living organisms for repopulation or ornamentation. Cultivation systems can be freshwater or seawater. The most common crops correspond to planktonic organisms (microalgae and Artemia), macroalgae, molluscs, crustaceans and fish.
  • dietary additive refers to a composition intended to be ingested together with the normal diet of the animal.
  • the additive described in the invention may comprise at least one probiotic, alone or in combination with other ingredients, preferably salts of organic acids.
  • promoters or stimulants of Growth can be administered in different ways, whether injected, in implants or as an additive in animal feed or feed. Administration as an additive in the food or feed is preferred. In the present invention, the effect on growth is measured as an increase in biomass.
  • organic acid refers to compounds that contain in its formula one or more carboxylic groups (-COOH), proton generators, which may also have different functional groups such as hydroxy acids, keto acids, aromatic acids , heterocyclic compounds, as well as amides and lactones.
  • the organic acids used in the present invention are preferably volatile fatty acids, preferably short chain and from which can be selected: butyric acid, propionic acid, formic acid, lactic acid, citric acid, lauric acid, cupric acid, caprylic acid, caproic acid, acetic acid, among others.
  • the proportions in which the organic acid is found in the animal feed additive described in the present invention usually vary between 30 and 70% by weight of total wet product, the preferred proportion being 50%.
  • probiotic refers to any type of viable microorganism applied to an animal or human host, and which beneficially affects the host, due to its beneficial effects, on health or on the increase of the resistance to diseases, which it may have on its consumer.
  • Probiotics may exhibit one or more of the following, non-limiting characteristics: non-pathogenic or non-toxic to the host; they are present as viable cells, capable of surviving in the intestinal environment (for example, at low pH and acids and gastrointestinal secretions), adhesion to epithelial cells, particularly to epithelial cells of the gastrointestinal tract, microbicidal or microbiostatic activity or effect towards pathogenic bacteria; anticancer activity; immune modulation activity; activity modulating the activity towards the endogenous flora; improvement of the health of the urogenital tract; antiseptic activity in or around wounds; diarrhea reduction; reduction of allergic reactions; reduction in neonatal necrotizing enterocolitis; reduction in inflammatory bowel disease and reduction of intestinal permeability.
  • the term "viable” refers to a living microorganism capable of reproducing and / or colonizing.
  • the singular forms “a”, “a”, and “the” include plural reference unless the context clearly indicates otherwise.
  • the shrimp were fed with the standard food to which the different additives of the invention were added to the concentration of 2g / Kg standard diet: ECOBI OL containing the probiotic CECT 5940 (first column-grid bar), or ECOBIOL PLUS containing the CECT 5940 + BP70 probiotic (second column-white bar), or ECOBIOL SUPER containing the combination of CECT 5940 + CECT 953 + BP70 probiotics (third column-black bar) or exclusively the standard diet (control group) (fourth column- striped bar).
  • the time expressed in days is shown on the X axis and the biomass expressed in grams on the Y axis. * p ⁇ 0.05 vs control.
  • FIG. 4 Litopenaeus vannamei biomass of approximately 7.0 g weight, analyzed every 10 days, for a total period of 60 days.
  • the shrimp were fed with the standard food to which the different additives of the invention were added to the concentration of 2g / kg of standard diet: ECOBIOL containing the probiotic CECT 5940 (first column-grid bar), or ECOBIOL PLUS containing the CECT 5940 + BP70 probiotic (second column-white bar), or ECOBIOL SUPER containing the combination of CECT 5940 + CECT 953 + BP70 probiotics (third column-black bar) or exclusively the standard diet (control group) (fourth column- striped bar).
  • the time expressed in days is shown on the X axis and the biomass expressed in grams on the Y axis. * p ⁇ 0.05.
  • Figure 5. Litopenaeus vannamei survival percentage of approximately 7.0 g weight, analyzed every 10 days, for a total period of 60 days feeding shrimp with a standard diet to which the different additives of the invention were added to the concentration of 2g / kg of standard diet: ECOBIOL containing the probiotic CECT 5940 (broken line with rhombus), or ECOBIOL PLUS containing the probiotic CECT 5940 + BP70 (continuous line with circle), or ECOBIOL SU PER containing the combination of CECT 5940 + CECT 953 + BP70 probiotics (dashed line with triangle) or exclusively the standard diet (control group) (continuous line with a cross).
  • the time expressed in days is shown on the X axis and the survival expressed as a percentage on the Y axis.
  • Figure 7 Response of the digestive enzyme activity in the hepatopancreas of the shrimp Litopenaeus vannamei, given the stimulation of diets containing the different types of probiotics: ECOBIOL containing the probiotic CECT 5940 (dashed line with rhombus), or ECOBIOL PLUS containing the probiotic CECT 5940 + BP70 (continuous line with circle), or ECOBIOL SUPER containing the combination of the probiotics CECT 5940 + CECT 953 + BP70 (dashed line with triangle) or exclusively the standard diet (control group) (continuous line with square). In time 0 the shrimp still did not receive the food; 1, 2, 3, 4 and 5h correspond to the time after the shrimp received the food.
  • the bars indicate the initial body weight (IBW), the final body weight after 30 days (FBW1), the final body weight after 60 days (FBW2), weight gain after 30 days (WG1), and Weight gain after 60 days (WG2).
  • B The figure shows the specific growth rate (SGR) of each of the study groups in the two months of the study.
  • SGR specific growth rate
  • PER protein efficacy ratio
  • Figure 9 Intestinal morphology of Nile Tilapia O. niloticus after 2 months fed with the probiotic of the invention ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940).
  • FIG. 1 Photograph of a cross-section of the proximal part of the intestine stained with hematoxylin & Eosin (H&E) showing the height of folding (double arrows), mucus-secreting cells (arrowheads) and intraepithelial lymphocytes (I EL) (arrows). Scale bar: 50 ⁇ .
  • B The figure shows the height of the villi (mean ⁇ SD) in the proximal, middle and distal parts of the intestine.
  • the asterisk (*) indicates a significantly greater height of hairiness in the proximal part of the large intestine compared to other parts of the intestine, within the same group.
  • G1 control group fed a basal diet.
  • a cross section of the distal part of the intestine stained by staining of alcian blue showed few mucus-secreting cells (arrow) in the control group (C) and numerous mucus-secreting cells in the group supplemented with the probiotic ECOBIOL ( ⁇ . amyloliquefaciens CECT 5940) (D).
  • A red blood cell count.
  • B Hemoglobin content.
  • C % PCV (Packed Cell Volume).
  • D White blood cell count.
  • E Glucose level.
  • G1 control group fed a basal diet.
  • G2 group fed a basal diet supplemented with the probiotic
  • B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 9 cfu / kg.
  • G3 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 7 cfu / kg.
  • FIG. 11 Constituents of the body of Nile Tilapia O. niloticus fed with different concentrations of the ECOBIOL additive containing the probiotic B. amyloliquefaciens CECT 5940, for 2 months. The bars indicate% crude protein (A),% crude lipids (B), ash content (dust or impurities) (C) and% moisture (D).
  • G1 control group fed a basal diet.
  • T1 43% fishmeal (HP) and 25% soy cake (TS)
  • T1 43% fishmeal (HP) and 25% soy cake (TS)
  • T8 TS + ECOBIOL + BP-70 Figure 14. Food consumption (expressed in Kg) of the rainbow trout O.mykiss analyzed 60 days after starting treatment. The experimental design is explained in Example 6. Each of the treatments analyzed comprises:
  • T1 43% fishmeal (HP) and 25% soy cake (TS)
  • T1 43% fishmeal (HP) and 25% soy cake (TS)
  • T1 43% fishmeal (HP) and 25% soy cake (TS)
  • One aspect of the present invention relates to an additive for feeding aquatic animals comprising the combination of at least two species belonging to the genus Bacillus, selected from B. amyloliquefaciens and Bacillus cereus.
  • the additive of the invention comprises the CECT 5940 strains of Bacillus amyloliquefaciens and the CECT 953 strain of Bacillus cereus.
  • the additive for feeding aquatic animals may further comprise other probiotics selected from any of the following genera: Bifidobacterium, Bacteroides, Clostridium, Fusobacterium, Melissococcus, Propionibacterium, Streptococcus, Enterococcus, Lactococcus, Staphylococcus, Peptostcococus, , Bacillus, Pediococcus, Micrococcus, Leuconostoc, Weissella, Aerococcus, Oenococcus and Lactobacillus.
  • probiotics selected from any of the following genera: Bifidobacterium, Bacteroides, Clostridium, Fusobacterium, Melissococcus, Propionibacterium, Streptococcus, Enterococcus, Lactococcus, Staphylococcus, Peptostcococus, , Bacillus, Pediococcus, Micrococcus, Leuconostoc, Weis
  • the probiotics comprise at least one suitable strain or subspecies from among: Enterococcus, Streptococcus, Lactobacillus, Lactococcus, Bifidobacterium and Pediococcus and / or combinations thereof.
  • the strain is selected from the genus Pediococcus, preferably from the species Pediococcus acidilactici, and in a more preferred embodiment, the most preferred probiotic is Pediococcus acidilactici strain CNCM MA 18/5 M, deposited in the Collection National Crops of Microorganisms (CNCM) of the Pasteur Institute in Paris.
  • the additives described in the present invention include probiotics in an amount suitable to improve the immune system, to increase the beneficial effects of the probiotics and / or to increase the biomass of the animals and / or extend their life.
  • food additives comprise approximately 10 5 to 10 10 CFU / g of feed for each of the probiotics used, with a concentration of approximately 10 6 CFU / g of feed being preferred, of each of the probiotics used.
  • the person skilled in the art can determine the appropriate amount of probiotics that is added to the additive of the invention. These factors that can be taken into account are the average consumption of certain types of compositions of different animals, if the animal that intends to ingest dietary supplements has a particular health problem, well-being or nutritional needs, or suffers of a disease or disorder, the age, sex, size or species of the animal.
  • concentrations of the probiotics to be added to the additive of the invention can be calculated based on the energy and nutrient requirements of the animal.
  • the additive further comprises at least one salt of an organic acid.
  • the organic acids are selected from any of the following: butyric, propionic, formic, lactic, citric, lauric, cupric, caprylic, caproic or acetic.
  • the salts of the organic acids are selected from any of the list: sodium, calcium, cupric or potassium.
  • the proportions in which the organic acid salt is found in the additive for animal feed described in the present invention usually varies between 30 and 70% by weight of the final wet additive, the preferred proportion being 60%.
  • the organic acid salt comprising the additive of the invention is the sodium salt of butyric acid (sodium butyrate), although any of the salts of the acids described previously may be used.
  • the additive of the invention is characterized in that it comprises a combination of the CECT 5940 probiotics of B. amyloliquefaciens and CECT 953 of B. cereus together with sodium salt of butyric acid.
  • the additives of the invention may additionally also comprise substances such as: minerals, vitamins, proteins, amino acids, dyes, preservatives, etc.
  • minerals include for example: calcium, phosphorus, potassium, sodium, iron, chlorine, copper, zinc, magnesium, manganese, selenium, etc.
  • vitamins include for example: Vitamin A, different types of Vitamin B (niacin, pantothenic acid, folic acid, biotin) Vitamin D and Vitamin K.
  • Another of the objects described in the present invention relates to the use of the additives described herein in the breeding of aquatic animals, as growth promoters of said animals, being able to favor the food conversion factor, as well as the specific activity of digestive enzymes, preferably of lipases, proteases, amylases and chymotrypsins.
  • the additives described herein are used to promote the health and welfare of aquatic animals.
  • the probiotics described herein preferably the probiotics selected from B. amyloliquefaciens, B. cereus, B. subtilis and B. licheniformis and / or combinations thereof, are used in animal husbandry aquatic
  • the probiotics used for the breeding of aquatic animals are preferably the CECT 5940 probiotic of B. amyloliquefaciens and the CECT 953 probiotic of B. cereus.
  • the probiotics used for the breeding of aquatic animals are characterized in that they can also include an additional probiotic of the genus Pediococcus, preferably the species Pediococcus acidilactici and more preferably the strain CNCM MA 18/5 M, deposited in the Collection National Crops of Microorganisms (CNCM) of the Pasteur Institute in Paris.
  • the probiotics used for the breeding of aquatic animals are characterized in that they further comprise at least one salt of an organic acid, said salt of the organic acid being preferably in a proportion of between 30-70% in wet weight, a proportion of 60% being more preferable.
  • the organic acids are selected from any of the following: butyric, propionic, formic, lactic, citric, lauric, cupric, caprylic, caproic or acetic.
  • the salts of organic acids are selected from any of the list: sodium, calcium, cupric or potassium.
  • the probiotics used for the breeding of aquatic animals are characterized in that the organic acid salt is the sodium salt of butyric acid.
  • the probiotics used for the breeding of aquatic animals comprise a combination of the CECT 5940 probiotics of B. amyloliquefaciens and CECT 953 of B. cereus together with sodium salt of butyric acid.
  • the probiotics used for the breeding of aquatic animals also have the ability to modulate the immune response and exert a bactericidal effect against pathogenic microorganisms.
  • the probiotics described herein also have the ability to exert a bioremediating action, thus helping to maintain the environment of the surfaces on which they are located, preferably thanks to secretion. of exo-enzymes that break down organic matter and decrease the COD (chemical oxygen demand) accepted parameter as an indicator of water quality.
  • aquatic animals are selected from any of the list: mollusks, crustaceans, tilapia, gilthead sea bass, and salmonids, with crustaceans being preferred, preferably shrimp. All percentages expressed herein are by weight of the additive composition based on dry matter unless specifically indicated otherwise.
  • Example 1 Growth response and survival of the white shrimp Litopenaeus vannamei fed with a standard diet supplemented with the additives of the invention.
  • Shrimp of the species Litopenaeus vannamei randomly selected, with an average weight of 0.85 g were used. These shrimp were previously acclimatized for 72 hours in a 2500 liter tank of seawater with 36.0 UPS (practical salinity units), constant aeration (> 4.0 mg / l oxygen), controlled temperature (30 to 34 ° C) and pH from 7.5 to 8.0.
  • the shrimp were grown in 10 L aquariums, with sea water and keeping the quality variables mentioned above.
  • the tests were carried out with a total of 8 shrimp per aquarium with six replications for each of the food additives used in the present invention. The experiment lasted 60 days, with biometrics every 10 to 10 days in order to assess growth, survival and biomass rates.
  • Biomass refers to the sum of the individual weights of shrimp present in each of the treatments with the different dietary additives.
  • a commercial feed / feed commonly used for feeding shrimp with 35% protein was used, which was ground and sieved at 200 microns.
  • the different probiotics were added as an additive to the standard diet at a rate of 2g / kg of food. Once the additive was incorporated into the standard diet, the mixture was homogenized and passed through a meat grinder and finally by a drying oven at 40 ° C for 12 hours. The food was placed in feeders; food not consumed after two hours was removed and subsequently weighed for analysis.
  • the four analyzed diets containing the dietary supplements or additives described in the present invention are described in Table 1.
  • this term includes both the standard diet supplied to the controls, formed by the commercial food indicated above, and the mixture thereof with the different additives of the invention.
  • the ECOBIOL probiotic comprises the bacteria B. amyloliquefaciens strain CECT 5940, the probiotic ECOBIOL PLUS containing the bacteria B. amyloliquefaciens strain CECT 5940 together with the sodium salt of the butyric acid BP70.
  • the sodium salt of butyric acid specifically the composition of Norel, SA called BP-70, is made up of 70% by weight of sodium butyrate and 30% by weight of vegetable fats. 30% of vegetable fat protects approximately 43% of total sodium butyrate, so the BP-70 product can be said to be made up of 30% protected sodium butyrate and 40% unprotected sodium butyrate .
  • He ECOBIOL SUPER probiotic contains the combination of bacteria B. amyloliquefaciens strain CECT 5940, together with B. cereus strain 953 and together with BP-70.
  • the food was added to satiety three times a day using feeders.
  • the food conversion factor (FCA) was calculated in grams of food per gram of biomass extracted; using the values of the food added daily, the unconsumed and the shrimp biomass obtained at the end of the 60 days of the experiment.
  • Shrimp growth and survival were evaluated every 10 days by recording the average weight and the number of shrimp respectively.
  • the expression and activity of digestive enzymes is affected by a series of limiting factors such as: physical-chemical parameters of water (pH, oxygen, salinity and temperature), age and size of shrimp, ontogenetic changes, fasting, diet ingredients , level and protein source, level and type of binders, growth promoting additives, quantity and frequency of feeding, circadian cycles, molting cycle and even the cultivation water.
  • physical-chemical parameters of water pH, oxygen, salinity and temperature
  • age and size of shrimp ontogenetic changes, fasting, diet ingredients , level and protein source, level and type of binders, growth promoting additives, quantity and frequency of feeding, circadian cycles, molting cycle and even the cultivation water.
  • ECOBIOL ECOBIOL PLUS and ECOBIOL SUPER, juvenile L vannamei shrimp were used, with an average weight of 6 g, which were maintained fasting for 12 hours and previously selected in intermuda stages.
  • the intermuda is known as the sequence of transformations between two molts (elimination of the old exoskeleton and the formation of a new and generally larger tegument), in which period a complete cycle of morphological, physiological and biochemical modifications, responsible for the increase.
  • the measurements of said enzymatic activity were carried out in intervals of one hour, for a time of 5 hours.
  • the activity and production of digestive enzymes in the hepatopancreas of crustaceans is mainly controlled by hormones.
  • the hepatopancreas unlike the intestine and stomach, has a greater enzymatic activity, suggesting the importance of this organ in the synthesis and secretion of digestive enzymes.
  • the protease, lipase, amylase and chymotrypsinase activity was determined in the enzymatic extracts prepared by the methodology proposed by Galgani F. (Galgani, F. PhD. Thesis liable ⁇ ix-Marseille //. Etude des digestive proteases of crevettes peneides (Crustacean Pickled) France. 1983) in hepatopancreas extracted from shrimp, at the indicated intervals previously and that were stored, for said analysis, at a temperature of - 48 ° C.
  • the concentration of proteins present in said enzymatic extracts was determined by the Bradford method.
  • Clostridia All strains of Clostridia were grown in agar-clostridium medium at an approximate concentration of 10 6 CFU / plaque. With the exception of B. amyloliquefaciens CECT 5940, which was grown at 30 ° C, the rest of the strains were incubated at 37 ° C in the absence of oxygen, inside anaerobiosis bottles.
  • the plates are incubated at the corresponding temperatures for each of the pathogenic microorganisms, to allow the growth of the target organism. After 24 hours, the presence or absence of a growth inhibition halo is determined. All sampling was done in duplicate, both in the collection of supernatants, and in the sowing of plates.
  • the concentration of pathogenic bacteria 10 6 U FC / plaque was inoculated with the appropriate medium.
  • Several notches of a size of 6 mm in diameter were made in the culture plates of the pathogenic microorganisms and the supernatant of B. amyloliquefaciens CECT 5940 was introduced in each (50 ⁇ ).
  • the plates were incubated at 4 ° C for 2 hours to allow the different components of the supernatant to diffuse into the plate culture medium. After that, all plates were incubated at 37 ° C for 24 hours and the inhibition halo was determined in order to demonstrate the bactericidal effect.
  • the pathogenic strains evaluated were:
  • Yersinia enterocolitica CECT 754 All strains of E. coli were selected according to the phenotype (0: 147 H: 7). The rest are pathogenic strains known according to the CECT (Spanish Crop Collection Type), except Enterococcus, which were selected as lactic acid bacterial strains (LAB).
  • Vibrio genus bacteria are Gram-negative bacteria commonly found in estuaries and marine waters, usually in temperate and tropical climates. Some species, such as the V. parahaemolyticus species, can cause gastroenteritis in humans. Natural guests of V. parahemolyticus include crabs, shrimp, turtles, oysters, lobsters and fish. The species V. gastroenteritis is often associated with infection in shrimp.
  • the two strains were grown in Nutrient Broth medium (Biokar) supplemented with 3% v / v NaCI, and incubated in an orbital shaker at the temperatures recommended in each case by the CECT for 16 hours.
  • the results show that the supernatants obtained from the cultures of ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940), as previously described, showed halos of inhibition around the traces made on cultures of the pathogenic species V. parahemolyticus CECT 511, but not, against the cultures of V. harveyi CECT 525.
  • the results indicate that the strain V.
  • B. amyloliquefaciens CECT 5940 contains some compound, bacteriocin type, that inhibits the growth of Vibrio parahaemolyticus CECT 511.
  • the numbers shown in Table 4 indicate the diameter of the inhibition halo in corresponding millimeters to each of the supernatants tested (it should be noted that the well in which the sample is applied has a diameter of 6 mm which is also included in the size of the halo).
  • Example 4 Production capacity of organic acids by B. amyloliquefaciens CECT 5940 under anaerobic conditions.
  • the objective of the present example is to evaluate the production capacity of lactic acid of the additive of the invention ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940) under self-generated anaerobiosis conditions.
  • ECOBIOL ⁇ . Amyloliquefaciens CECT 5940
  • the production of lactic acid excreted to the lumen of the intestine causes acidification of the medium resulting in a preferential growth of the acidophilic flora, having a beneficial effect on health intestinal.
  • the preferential growth of this type of microorganisms displaces the pathogenic bacteria through the known mechanism of competitive exclusion.
  • the growth and culture conditions of the strains of B. amyloliquefaciens CECT 5940 have already been described throughout this document.
  • the composition of the experimental medium is as follows:
  • composition of the medium described above mimics the proportion of proteins and carbohydrates in the intestinal lumen of the animals.
  • CFU / ml According to the technique of serum dilution and subsequent colony counting in the appropriate culture medium of B. amyloliquefaciens CECT 5940.
  • Lactic acid production The methods used in the process. n spectophotometric, and the determination of the presence of NADH at an absorbance of A340 in centrifugal and cell-free fermentation extract samples, with the Boehringer Mannheim enzyme systems.
  • Acetic acid production The method used was spectophotometric and the determination of the presence of NADH at A340 in samples of centrifugal and cell-free fermentation extracts, with Boehringer Mannheim enzymatic systems.
  • Example 5 Growth response, intestinal morphology, hematology and body composition of Nile Tilapia (Oreochromis niloticus (L.)) fed a standard diet supplemented with the additives of the invention.
  • the use of the additive of the invention ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940) as a probiotic in Nile tilapia is evaluated.
  • a total of 120 O. niloticus (L.) fry (average weight of 9.4 ⁇ 0.3 g) They were divided into 3 groups (20 fish / group) in duplicate.
  • the group called G1 was fed a basal diet as the control group; while the groups called G2 and G3 were fed the basal diet to which the additive ECOBIOL ( ⁇ . amyloliquefaciens CECT 5940) was added in the final levels at a spore concentration of 1x10 9 and 1x10 7 cfu / kg respectively.
  • ECOBIOL ⁇ . amyloliquefaciens CECT 5940
  • the use of a higher concentration of probiotics in the animals' diet increased the height of the intestinal villi, especially in the proximal part of the intestine.
  • the G2 group presented a significantly higher number of mucus-secreting cells (goblet cells), in the proximal and distal parts of the intestine, than the G3 or G1 groups ( Figure 9A-E).
  • Example 6 Evaluation of the additive of the invention ECOBIOL (B. amyloliquefaciens CECT 5940) and Gustor BP-70 as growth promoters in diets with fishmeal or soy cake for rainbow trout fry (Oncorhynchus mykiss).
  • the objective of the present example is to evaluate the addition to a diet of rainbow trout fry (O. mykiss), two growth promoters, ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940) and Gustor BP-70, alone or in combination, at the level 0.1%, in diets based on fishmeal or soy cake, on the productive behavior, taking into account the parameters of growth (weight gain and height), food conversion and survival of these animals.
  • the facilities of the Vinchos Fish Production Center located in the district of Canchayllo, belonging to the SAIS "Tupac Amaru", in the department of Jun ⁇ n (Peru) were used.
  • the experimental diets were prepared at the Balanced Food Plant of the Social Research and Projection Program in Food, School of Zootechnics, of the National Agrarian University La Molina (Lima, Peru), during the months of March, April and May of 2012, with a duration of 60 days.
  • 170000 rainbow trout fry were installed in 30 ponds of 5 x 0.60 meters (experimental units), with capacity for 5000 fish each.
  • Three entries were made, in periods of 15 days (replicas); the first with fish with an average weight of 2.2 g and 6.0 cm in size; after 15 days, fish with an average weight of 0.15 g and 2.25 cm in size were installed and after 15 days, fish with an average weight of 0.08 g and 1.90 cm in size.
  • Two commercial diets were formulated, one based on fishmeal (43%) and one based on soybean cake (50%), linear programming was used at minimum cost, according to the recommendations of the NRC (1993). To each experimental diet 0.1% of
  • ECOBIOL ⁇ . Amyloliquefaciens CECT 5940
  • BP-70 BP-70 or the mixture of both, giving rise to 8 treatments.
  • Each of the treatments includes:
  • T1 43% fishmeal (HP) and 25% soy cake (TS)
  • Example 7 Use of ECOBIOL (B. amyloliquefaciens CECT 5940) as a bioremediation agent.
  • Water quality and soil quality management is considered one of the most important aspects of pond aquaculture. While water quality parameters, such as dissolved oxygen, pH, or ammonia concentrations affect essential functions of the body, the state of the bottom of the ponds and the exchange of substances between the soil and water greatly affects water quality
  • the accumulation of waste will increase the demand for oxygen by bacteria in order to perform their metabolism and degrade organic matter, favoring the development of anaerobic areas.
  • These anoxic sediments will be in contact with the oxygen-rich water column, producing an alteration of the environmental conditions suitable for a healthy development of the organisms that inhabit these ponds.
  • ammonia can diffuse in the water column not only as a result of fish excretion, but also after microbial decomposition of organic matter.
  • Bacillus spp. They are considered as bioremediation agents, a concept that refers to the use of microorganisms that help in maintaining the environment of the appropriate pond thanks to the secretion of exo-enzymes that break down organic matter.
  • the purpose of the present example is to evaluate the in vitro capacity of ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940) as a bioremediation agent.
  • COD chemical oxygen demand
  • the soluble COD measurements in the supernatant were made after 15 min of sedimentation after homogenization of the media, while the total COD measurements were made immediately after homogenization. The measurements were carried out on day 0 (initial), day 3 and day 7. The temperature was maintained at 25 ° C. The results revealed that the total COD was progressively reduced in the treatment groups, especially in those treated with ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940). In addition, the layer of water and mud was reduced to 4 cm deep. This indicates lower levels of waste, and consequently, better environmental conditions, due to the bioremediation action of treatment with ECOBIOL ( ⁇ . Amyloliquefaciens CECT 5940) (See Table 8).

Abstract

The invention relates to an additive for feeding aquatic animals, comprising the combination of two species pertaining to the genus Bacillus, said species being B. amyloliquefaciens and B. cereus, preferably the strains CECT 5940 of B. amyloliquefaciens and CECT 953 of B. cereus, in combination with an organic acid salt, preferably with the sodium salt of butanoic acid. The additives for feeding aquatic animals described in the present invention can also comprise other bacterial strains with a probiotic capacity, preferably pertaining to the species Pediococcus acidilactici.

Description

ADITIVOS PARA ALIMENTACIÓN DE ANIMALES ACUÁTICOS QUE CONTIENEN PROBIÓTICOS.  ADDITIVES FOR THE FEEDING OF AQUATIC ANIMALS CONTAINING PROBIOTICS.
CAMPO DE LA INVENCIÓN FIELD OF THE INVENTION
La presente invención divulga aditivos para la alimentación de animales acuáticos, aditivos que contienen al menos un probiótico que, además, puede ir acompañado de al menos una sal de un ácido orgánico. Dichos aditivos son utilizados como promotores o estimulantes del crecimiento y mejoradores del estado sanitario del animal. Por tanto, la presente invención se engloba dentro del campo de la acuicultura y más específicamente dentro de la producción, alimentación y salud animal. The present invention discloses additives for feeding aquatic animals, additives containing at least one probiotic which, in addition, may be accompanied by at least one salt of an organic acid. These additives are used as promoters or growth stimulants and enhancers of the animal's health status. Therefore, the present invention is encompassed within the field of aquaculture and more specifically within animal production, food and health.
ESTADO DE LA TÉCNICA La acuicultura ha tenido en los últimos años adelantos significativos en la producción de una amplia variedad de organismos acuáticos tanto de consumo humano como de especies de ornamentación. Debido a las condiciones de cría, como por ejemplo las altas densidades de animales y a las variaciones en la calidad del agua, los organismos están sujetos a un estrés constante que se traduce en una elevada tasa de mortalidad, así como en bajas tasas de crecimiento y de eficiencia alimenticia, además de incrementarse la presencia e incidencia de enfermedades ocasionadas por patógenos oportunistas. La necesidad de una acuicultura sostenible y rentable ha impulsado la búsqueda de soluciones aceptables para optimizar la producción de una manera natural y respetuosa con el medio ambiente. STATE OF THE TECHNIQUE Aquaculture has had significant progress in recent years in the production of a wide variety of aquatic organisms for both human consumption and ornamentation species. Due to the breeding conditions, such as high animal densities and variations in water quality, organisms are subject to constant stress that results in a high mortality rate, as well as low growth rates and of food efficiency, in addition to increasing the presence and incidence of diseases caused by opportunistic pathogens. The need for sustainable and profitable aquaculture has driven the search for acceptable solutions to optimize production in a natural and environmentally friendly way.
Para sobrellevar estos problemas se han utilizado suplementos y/o aditivos alimenticios que evitan la aparición de enfermedades y que además operan como promotores del crecimiento. Entre dichos suplementos se encuentran las hormonas, los antibióticos y algunas sales. Sin embargo, su uso inapropiado puede presentar efectos adversos en el animal o en el consumidor final, así como dar lugar a resistencia cruzada en los animales de cría, frente a bacterias patógenas, produciendo desequilibrios ambientales y pérdidas económicas de las explotaciones acuícolas. Por lo tanto, la tendencia en la actualidad en acuicultura, es la búsqueda de una dieta que no sólo cubra las necesidades alimenticias de los animales, sino que además refuerce su estado inmunológico y sanitario, en general y reduzca los problemas patológicos sin utilizar medicamentos, para así conseguir mejorar su producción, evitar problemas con la seguridad de los alimentos obtenidos a partir de los animales de cría e incrementar los rendimientos económicos de las explotaciones. Para la consecución de estos objetivos, una de las vías de obtención ha sido el control de la flora intestinal de los animales de cría, utilizándose para ello los probióticos (Robertson, P.A.W. et al. Aquaculture 2000; 185: 235-243; Verschuere, L, G. et al. Microbiological Molecular 2000; 64: 655-671 ; Gullian, . et al., Aquaculture 2004; 233: 1-14; Balcázar, J.L.,et al. Veterinary Microbioiogy 2006; 114: 173-186; Gatesoupe, F.J. Journal of Molecular Microbiologlcal Bioiechnology. 2008;14: 107-114) que pueden definirse como microorganismos viables que administrados en la dieta promueven el bienestar de los organismos de cría por medio de la estimulación del sistema inmune, así como del establecimiento del balance microbiano intestinal en dichos animales de cría, mediante la exclusión de microorganismos potencialmente patógenos (I rianto, A. y B. Journal of Fish Diseases 2002; 25: 333-342; Irianto, A. y B. Austin. Journal of Flsh Diseases 2003; 26: 59-62; Lara-Flores, M., et al. Aquaculture 2003; 216: 193-201.). El uso de probióticos en la producción animal es una forma eficaz de control de la microflora intestinal de los animales de cría y ha demostrado ser, tanto un buen sustituto como un buen complemento, a los antibióticos promotores del crecimiento. Los probióticos son ampliamente utilizados en la cría de cerdos y aves, pero poco se ha hecho para incorporarlos en la acuicultura. To overcome these problems, supplements and / or food additives have been used that prevent the onset of diseases and also operate as growth promoters. Among these supplements are hormones, antibiotics and some salts. However, its inappropriate use may have adverse effects on the animal or the final consumer, as well as giving rise to cross resistance in breeding animals, against pathogenic bacteria, causing environmental imbalances and economic losses of aquaculture farms. Therefore, the current trend in aquaculture is the search for a diet that not only covers the nutritional needs of animals, but also reinforces their immunological and sanitary status, in general and reduces pathological problems without using medications, in order to improve its production, avoid problems with food safety obtained from breeding animals and increase the economic yields of farms. For the achievement of these objectives, one of the ways of obtaining this has been the control of the intestinal flora of the breeding animals, using probiotics for this purpose (Robertson, PAW et al. Aquaculture 2000; 185: 235-243; Verschuere, L, G. et al. Microbiological Molecular 2000; 64: 655-671; Gullian,. Et al., Aquaculture 2004; 233: 1-14; Balcázar, JL, et al. Veterinary Microbioiogy 2006; 114: 173-186; Gatesoupe, FJ Journal of Molecular Microbiologlcal Bioiechnology. 2008; 14: 107-114) that can be defined as viable microorganisms that administered in the diet promote the welfare of breeding organisms through the stimulation of the immune system, as well as the establishment of intestinal microbial balance in such breeding animals, by excluding potentially pathogenic microorganisms (I rianto, A. and B. Journal of Fish Diseases 2002; 25: 333-342; Irianto, A. and B. Austin. Journal of Flsh Diseases 2003; 26: 59-62; Lara-Flores, M., et al. A quaculture 2003; 216: 193-201.). The use of probiotics in animal production is an effective way to control the intestinal microflora of breeding animals and has proven to be both a good substitute and a good complement to growth-promoting antibiotics. Probiotics are widely used in pig and poultry farming, but little has been done to incorporate them into aquaculture.
En este sentido, los animales acuáticos difieren de los animales terrestres en el nivel de interacción entre la microbiota intestinal y el ambiente que los rodea. Las bacterias presentes en el ambiente acuático influyen en la composición de la microflora del intestino de los animales acuáticos y viceversa. La composición de la comunidad bacteriana del tracto intestinal de los animales acuáticos es diferente a lo que se encuentra en los animales terrestres. En el ambiente marino predominan las bacterias Gram negativas y en menor proporción las Gram positivas; estas usualmente constituyen la mayoría de las bacterias que normalmente se presentan en la microflora asociada a los camarones silvestres y de cultivo. La gran mayoría de los microbios presentes en el ambiente marino (bacterias, virus, hongos o parásitos) son inocuos o son controlados exitosamente por los mecanismos internos de defensa de los organismos en cultivo. Las etapas tempranas del ciclo de vida de los organismos acuáticos suelen ser más susceptibles a los ataques de dichos agentes, sobre todo cuando se llevan cultivos larvarios en forma intensiva, que por efecto del estrés provocado por las altas densidades, reduce el potencial de defensa de los organismos. La ruptura del equilibrio dinámico de la flora intestinal es provocada por el estrés que se genera por las condiciones intensivas de la producción animal, mencionadas previamente. Cuando descienden las concentraciones de bacterias beneficiosas, aparece la oportunidad para las bacterias menos deseables ó para que los patógenos potenciales se instalen y se multipliquen. In this sense, aquatic animals differ from terrestrial animals in the level of interaction between the intestinal microbiota and the surrounding environment. The bacteria present in the aquatic environment influence the composition of the microflora of the intestine of aquatic animals and vice versa. The composition of the bacterial community of the intestinal tract of aquatic animals is different from what is found in terrestrial animals. Gram negative bacteria predominate in the marine environment and Gram positive in a smaller proportion; these usually constitute the majority of the bacteria that normally occur in the microflora associated with wild and cultivated shrimp. The vast majority of microbes present in the marine environment (bacteria, viruses, fungi or parasites) are harmless or are successfully controlled by the internal defense mechanisms of organisms in culture. The early stages of the life cycle of aquatic organisms are usually more susceptible to attacks by such agents, especially when larval cultures are carried out intensively, which, due to the stress caused by high densities, reduces the defense potential of the organisms The breakdown of the dynamic balance of the intestinal flora is caused by the stress generated by the intensive conditions of animal production, mentioned previously. When concentrations of beneficial bacteria decrease, the opportunity for less desirable bacteria or for potential pathogens to install and multiply appears.
Existen diferentes especies bacterianas utilizadas como probióticos en acuicultura destacando, sobre todo, las bacterias acidolácticas, preferentemente pertenecientes al género Lactobacillus (Nikoskelainen, 8.A. et al. Fish Sellfísh Immunology 2003; 15: 443- 452; Balcázar, J.L. et al. British Journal of Nutrítion 2007; 97: 522-527; Gatesoupe, FJ. Journal of Molecular Microbioiogical Biotechnology. 2008; 14: 107-114). Bacterias de dicho género forman parte de la flora microbiana natural que se encuentran acompañando a los camarones en todos sus estadios de vida y parte de dichas bacterias presentan potencial para usarse como probióticos en la acuacultura. Sin embargo, debido a que esta práctica aún es reciente en la acuicultura, son pocas las especies de microorganismos que se usan, por lo que en la actualidad es necesario continuar seleccionando cepas con características probióticas. Además, puede ser beneficioso para complementar el sistema inmune, particularmente en el tracto gastrointestinal de los animales acuáticos, utilizar, en combinación con los probióticos, otros ingredientes o aditivos que potencien el beneficio de dichos probióticos en la salud y producción en acuicultura. There are different bacterial species used as probiotics in aquaculture, highlighting, above all, acid-lactic bacteria, preferably belonging to the genus Lactobacillus (Nikoskelainen, 8.A. et al. Fish Sellfísh Immunology 2003; 15: 443-452; Balcázar, JL et al. British Journal of Nutrition 2007; 97: 522-527; Gatesoupe, FJ. Journal of Molecular Microbioiogical Biotechnology. 2008; 14: 107-114). Bacteria of this genus are part of the natural microbial flora that are found accompanying shrimp in all their stages of life and part of these bacteria have potential to be used as probiotics in aquaculture. However, because this practice is still recent in aquaculture, few species of microorganisms are used, so it is currently necessary to continue selecting strains with probiotic characteristics. In addition, it may be beneficial to complement the immune system, particularly in the gastrointestinal tract of aquatic animals, to use, in combination with probiotics, other ingredients or additives that enhance the benefit of such probiotics in health and aquaculture production.
Mientras que los probióticos son útiles para la promoción de la salud de un animal, a menudo son difíciles de almacenar, manejar y administrar a dichos animales, más cuando dicha administración se realiza disolviendo el aditivo, junto con el alimento habitual de los animales, en el medio acuático. En este sentido, la formulación de alimentos no solo tiene que completar los requerimientos de los animales, debe también producir un alimento muy estable en el agua porque los animales acuáticos se al i m entan l enta y continuamente. Específicamente, el camarón detecta el ali mento a distancia por quimiorecepción, por lo que dicho alimento debe ser además atractante (que atraiga al animal) y palatable (que le guste el sabor), debiéndose además presentar una forma y composición uniforme. En este sentido, el uso de sustancias atractantes permite que los alimentos sean localizados y consumidos más rápido por los animales. Estos compuestos son moléculas muy solubles en agua y son de bajo peso molecular; como: aminoácidos, compuestos cuaternarios de amonio, trimetilamina, betaina (trimetilglicina), nucleótidos, aminas biogénicas y ácidos orgánicos. De manera comercial se encuentran disponibles en el mercado harinas solubles y aceites de pescado, moluscos ó crustáceos; que funcionan como excelentes atractantes. While probiotics are useful for promoting the health of an animal, they are often difficult to store, handle and administer to these animals, especially when such administration is done by dissolving the additive, along with the usual food of the animals, in The aquatic environment. In this sense, the food formulation not only has to complete the requirements of the animals, it must also produce a very stable food in the water because the aquatic animals are introduced continuously and continuously. Specifically, the shrimp detects the food at a distance by chemoreception, so that this food must also be attractive (that attracts the animal) and palatable (that likes the taste), and must also have a uniform shape and composition. In this sense, the use of attractive substances allows food to be located and consumed faster by animals. These compounds are very water soluble molecules and are of low molecular weight; as: amino acids, quaternary ammonium compounds, trimethylamine, betaine (trimethylglycine), nucleotides, biogenic amines and organic acids. Commercially available in the market soluble flours and fish oils, molluscs or crustaceans; They work as excellent attractants.
Existe, por tanto, una necesidad de nuevos aditivos para la alimentación de animales acuáticos, que contengan probióticos capaces de reforzar el sistema inmune evitando así la invasión por patógenos oportunistas y dando lugar a un incremento en la longevidad de los animales criados en cautividad mediante técnicas de acuicultura. Otro de los objetivos, de los aditivos incorporados en la dieta de los animales acuáticos es conseguir un mayor aprovechamiento del alimento y una actividad incrementada de las enzimas digestivas que se traduzca en un incremento en el crecimiento de los animales de cría y por consiguiente redunde en los beneficios económicos para las explotaciones acuícolas. There is, therefore, a need for new additives for feeding aquatic animals, containing probiotics capable of strengthening the immune system thus preventing invasion by opportunistic pathogens and resulting in an increase in the longevity of animals reared in captivity by means of techniques Aquaculture Another objective, of the additives incorporated in the diet of aquatic animals is to achieve greater use of food and an increased activity of digestive enzymes that results in an increase in the growth of breeding animals and therefore results in the economic benefits for aquaculture farms.
DESCRIPCIÓN DE LA INVENCIÓN Breve descripción de la invención DESCRIPTION OF THE INVENTION Brief description of the invention
La presente invención describe un nuevo aditivo alimenticio para animales acuáticos que comprende al menos dos cepas bacterianas, preferentemente en forma de espora, pertenecientes al género Bacillus y que se selecciona de entre Bacillus amyloliquefaciens y Bacillus cereus. The present invention describes a new food additive for aquatic animals comprising at least two bacterial strains, preferably in spore form, belonging to the genus Bacillus and selected from among Bacillus amyloliquefaciens and Bacillus cereus.
La cepa bacteriana Bacillus amyloliquefaciens CECT 5940 es una cepa bacteriana aislada por NOREL S.A., España depositada el 25 de Abril del 2001 en la Colección Española de Cultivos tipo sita en el Parque Científico de la Universidad de Valencia. Calle Catedrático Agustín Escardino, 9 de Paterna (Valencia) y, que se comercializa como el probiotico ECOBIOL. The bacterial strain Bacillus amyloliquefaciens CECT 5940 is a bacterial strain isolated by NOREL S.A., Spain deposited on April 25, 2001 in the Spanish Collection of Crops type sita in the Scientific Park of the University of Valencia. Calle Agustín Escardino Professor, 9 de Paterna (Valencia) and, which is marketed as the probiotic ECOBIOL.
El ECOBIOL es un probiotico en forma de esporas resistentes capaces de sobrevivir incluso al proceso de granulación y/o peletización del pienso. Una vez en el animal, donde la bacteria encuentra un medio adecuado para su desarrollo en términos de nutrientes temperatura y humedad, las esporas que componen el ECOBIOL germinan, pasando entonces la bacteria a producir todos los efectos beneficiosos para el animal. Dicho probiotico se caracteriza además porque presenta un mejor ratio de reproducción en comparación a otras esporas de Bacillus spp y además, es capaz de liberar compuestos químicos que tienen un efecto inhibidor en la población patógena. La cepa bacteriana Bacillus cereus CECT 953 es una cepa bacteriana aislada por NOREL S.A., España depositada el 25 de Octubre de 1988 en la Colección Española de Cultivos tipo sita en el Parque Científico de la Universidad de Valencia. Calle Catedrático Agustín Escardino, 9 de Paterna (Valencia) y, que se comercializa como el probiotico ESPORAFEED. ECOBIOL is a probiotic in the form of resistant spores capable of surviving even the process of granulation and / or pelletization of feed. Once in the animal, where the bacterium finds a suitable medium for its development in terms of temperature and humidity nutrients, the spores that make up the ECOBIOL germinate, then passing the bacteria to produce all the beneficial effects for the animal. Said probiotic is also characterized in that it has a better reproduction ratio compared to other Bacillus spp spores and is also capable of releasing chemical compounds that have an inhibitory effect on the pathogenic population. The bacterial strain Bacillus cereus CECT 953 is a bacterial strain isolated by NOREL SA, Spain deposited on October 25, 1988 in the Spanish Collection of Crops type sita in the Science Park of the University of Valencia. Calle Agustín Escardino Professor, 9 de Paterna (Valencia) and, which is marketed as the probiotic ESPORAFEED.
El ESPORAFEED es un probiotico en forma de esporas resistentes capaces de sobrevivir incluso al proceso de granulación de los piensos para alimentación animal. Dicho probiotico se caracteriza por resistir altas temperaturas de granulación, así como agentes físicos y acidificantes. Además, ESPORAFEED produce enzimas que mejoran la digestibilidad de la dieta. ESPORAFEED is a probiotic in the form of resistant spores capable of surviving even the process of granulation of feed for animal feed. Said probiotic is characterized by resisting high granulation temperatures, as well as physical and acidifying agents. In addition, ESPORAFEED produces enzymes that improve the digestibility of the diet.
Los aditivos descritos en la presente invención se adicionan a la dieta de los animales acuáticos, preferentemente en aquéllos animales de cría mediante acuicultura y que se seleccionan, entre otros, de entre cualquiera de la siguiente lista: crustáceos, moluscos, tilapia, dorada, lubina y salmónidos. The additives described in the present invention are added to the diet of aquatic animals, preferably in those animals farmed by aquaculture and which are selected, among others, from any of the following list: crustaceans, molluscs, tilapia, gilthead sea bass and salmonids.
El aditivo de la invención actúa como promotor natural del crecimiento, al mostrar una mejora en el factor de conversión del alimento, un incremento en el crecimiento de los animales y en la biomasa, así como un incremento en la supervivencia de los animales a los que se les administra dicho aditivo frente a los animales alimentados sin el aditivo. The additive of the invention acts as a natural growth promoter, showing an improvement in the feed conversion factor, an increase in the growth of animals and biomass, as well as an increase in the survival of the animals to which these additives are administered to animals fed without the additive.
El aditivo de la invención puede contener además otros ingredientes capaces de reforzar el sistema inmune y mejorar la digestibilidad del alimento dando lugar a un aumento en la acción de los probióticos. Entre dichos ingredientes se encuentran las sales de los ácidos orgánicos, siendo preferida la sal sódica del ácido butírico. The additive of the invention may also contain other ingredients capable of strengthening the immune system and improving the digestibility of the food resulting in an increase in the action of probiotics. Among these ingredients are salts of organic acids, with sodium salt of butyric acid being preferred.
Los ácidos orgánicos de cadena corta son capaces de reducir el pH a nivel intestinal lo que limita el desarrollo de patógenos y ayuda en la digestión de proteínas y, por otro lado, presentan habilidad para entrar en las bacterias, específicamente en aquéllas patógenas y bloquear su metabolismo. Su acción bactericida se ejerce preferentemente entre los géneros: Escherichia, Campylobacter, Clostridium y Salmonella, entre otros. En la presente invención se utiliza el producto de Norel S.A. España comercializado con el nombre de GUSTOR BP-70, a partir de aquí y, a lo largo de toda la invención lo llamaremos BP-70. El BP-70 está formado por la sal sódica del ácido butírico protegida, frente a una digestión temprana, con una matriz de grasas vegetales, que protegen solo una parte del ingrediente activo y permiten la liberación lenta del producto, asegurando así su acción potenciadora del crecimiento y bactericida en todo el tracto digestivo del animal. Esta protección parcial asegura que una parte del butirato llegue a las partes más lejanas del tracto digestivo de los animales, ejerciendo así su acción. Por una parte, el butirato sódico desprotegido ejercerá su acción en las partes del tracto digestivo más próximas. Por otra, el butirato sódico protegido, va a ejercer su acción en las partes del tracto digestivo más distales, una vez la capa protectora que impide su acción, se haya hidrolizado a lo largo del proceso digestivo. Organic short-chain acids are capable of reducing the pH at the intestinal level, which limits the development of pathogens and helps in the digestion of proteins and, on the other hand, they have the ability to enter the bacteria, specifically those pathogens and block their metabolism. Its bactericidal action is exerted preferably between the genera: Escherichia, Campylobacter, Clostridium and Salmonella, among others. In the present invention the Norel SA Spain product marketed under the name of GUSTOR BP-70 is used, from here and, throughout the entire invention we will call it BP-70. The BP-70 is formed by the sodium salt of protected butyric acid, against early digestion, with a matrix of vegetable fats, which protect only a part of the active ingredient and allow the slow release of the product, thus ensuring its potentiating action growth and bactericide throughout the digestive tract of the animal. This partial protection ensures that a part of the butyrate reaches the farthest parts of the digestive tract of animals, thus exercising its action. On the one hand, unprotected sodium butyrate will exert its action on the nearest parts of the digestive tract. On the other, the protected sodium butyrate will exert its action on the most distal parts of the digestive tract, once the protective layer that prevents its action has hydrolyzed throughout the digestive process.
Los aditivos descritos en la presente invención favorecen además la actividad específica de las enzimas digestivas, preferentemente de las lipasas, proteasas, amilasas y quimiotripsinas, así como el factor de conversión alimenticia, lo que da lugar a un mayor aprovechamiento del alimento y en consecuencia a una mayor biomasa de los animales. The additives described in the present invention further favor the specific activity of digestive enzymes, preferably of lipases, proteases, amylases and chymotrypsins, as well as the food conversion factor, which results in greater use of the food and consequently greater biomass of animals.
Las concentraciones de cada uno de los ingredientes que compren los aditivos de la invención, se incorporan en cantidades suficientes para conseguir las propiedades beneficiosas de los mismos, tales como mejorar el factor de conversión alimenticia, un mejor aprovechamiento del alimento, un incremento en su biomasa y un incremento en la longevidad de los individuos. The concentrations of each of the ingredients purchased by the additives of the invention are incorporated in amounts sufficient to achieve the beneficial properties thereof, such as improving the food conversion factor, a better utilization of the food, an increase in its biomass. and an increase in the longevity of individuals.
Otro objeto descrito en la presente invención se refiere al uso de los aditivos de la invención como promotores del crecimiento de los animales acuáticos, así como promotor de la salud y el bienestar de los mismos, al dotar los aditivos de la invención a los animales alimentados con los mismos de un sistema inmune reforzado. En este sentido, el virus del síndrome de la mancha blanca (WSSV, white spot syndrome virus, en sus siglas en inglés) es el principal patógeno del camarón y los brotes matan en pocos días a la totalidad de las poblaciones de camarones, siendo por lo tanto el responsable de grandes pérdidas de producción/ganancias en esta industria a nivel mundial. Además de infectar a los camarones, el virus tiene una amplia gama de huéspedes, como por ejemplo, crustáceos como cangrejos, langostas espinosas, cangrejos de río, etc. que pueden ser infectados con gravedad variable dependiendo de la etapa vital del crustáceo y de la presencia de factores estresantes externos (temperatura, salinidad, enfermedades bacterianas, contaminantes, etc). Los signos clínicos de la "mancha blanca" incluyen una súbita reducción del consumo de alimentos, letargo, pérdida de cutícula, decoloración y la presencia de manchas blancas de 0,5 a 2,0 mm de diámetro en la superficie interior del caparazón, apéndices y sobre la cutícula de los segmentos abdominales. Hasta ahora no existe ningún tratamiento efectivo para controlar la infección provocada por dicho virus, pero los animales acuáticos alimentados con los diferentes aditivos descritos aquí, al tener reforzado su sistema inmune gracias a los aditivos de la invención, no muestran signos de la enfermedad, por lo tanto, los aditivos de la invención son capaces de prevenir la infección por el virus de la mancha blanca. Another object described in the present invention relates to the use of the additives of the invention as promoters of the growth of aquatic animals, as well as promoter of their health and well-being, by providing the additives of the invention to fed animals. with them from a reinforced immune system. In this sense, the white spot syndrome virus (WSSV) is the main pathogen of shrimp and outbreaks kill all shrimp populations in a few days, being by therefore responsible for large production / profit losses in this industry worldwide. In addition to infecting shrimp, the virus has a wide range of hosts, such as crustaceans such as crabs, spiny lobsters, crayfish, etc. which can be infected with varying severity depending on the vital stage of the crustacean and the presence of external stressors (temperature, salinity, bacterial diseases, contaminants, etc.). The clinical signs of "white spot" include a sudden reduction in food consumption, lethargy, cuticle loss, discoloration and presence of white spots of 0.5 to 2.0 mm in diameter on the inner surface of the shell, appendages and on the cuticle of the abdominal segments. Until now there is no effective treatment to control the infection caused by said virus, but aquatic animals fed with the different additives described here, having their immune system reinforced thanks to the additives of the invention, show no signs of the disease. therefore, the additives of the invention are capable of preventing infection by the white spot virus.
Otro objeto de la presente invención se refiere a un método para promover el crecimiento de los animales acuáticos mediante la administración del aditivo descrito en la invención, dado que dicho aditivo es capaz de dar lugar a un mayor aprovechamiento del alimento consumido. Another object of the present invention relates to a method for promoting the growth of aquatic animals by administering the additive described in the invention, since said additive is capable of giving greater use to the food consumed.
Otros objetos, características y ventajas de la presente invención serán fácilmente evidentes para los expertos en la técnica. Other objects, features and advantages of the present invention will be readily apparent to those skilled in the art.
A efectos de la presente invención se definen los siguientes términos: For the purposes of the present invention the following terms are defined:
El término "acuicultura" se refiere al conjunto de actividades técnicas y conocimientos de cultivo de especies acuáticas vegetales y animales. Es una importante actividad económica de producción de alimentos, materias primas de uso industrial y farmacéutico, y organismos vivos para repoblación u ornamentación. Los sistemas de cultivo pueden ser de agua dulce o agua de mar. Los cultivos más habituales corresponden a organismos planctónicos (microalgas y Artemia), macroalgas, moluscos, crustáceos y peces. The term "aquaculture" refers to the set of technical activities and knowledge of cultivation of aquatic plant and animal species. It is an important economic activity of food production, raw materials for industrial and pharmaceutical use, and living organisms for repopulation or ornamentation. Cultivation systems can be freshwater or seawater. The most common crops correspond to planktonic organisms (microalgae and Artemia), macroalgae, molluscs, crustaceans and fish.
El término "aditivo dietético", "aditivo alimenticio" , "aditivo para alimentación" o "suplemento dietético", a efectos de la presente invención se refiere a una composición destinada a ser ingerida junto con la dieta normal del animal. El aditivo descrito en la invención puede comprender al menos un probiótico, solo o en combinación con otros ingredientes, preferentemente, sales de ácidos orgánicos. The term "dietary additive", "food additive", "food additive" or "dietary supplement", for the purpose of the present invention refers to a composition intended to be ingested together with the normal diet of the animal. The additive described in the invention may comprise at least one probiotic, alone or in combination with other ingredients, preferably salts of organic acids.
A efectos de la presente invención se denominan "promotores o estimulantes del crecimiento" a los aditivos que forman parte de la dieta animal y que cumplen con la función de mejorar el aumento de peso diario de los animales (GDP), así como el factor de conversión alimenticia. En la presente invención, los promotores o estimulantes del crecimiento pueden ser administrados de diferentes maneras, ya sean inyectados, en implantes o como un aditivo en el alimento o piensos de los animales. Se prefiere la administración como un aditivo en el alimento o pienso. En la presente invención, el efecto sobre el crecimiento se mide como incremento de la biomasa. For the purposes of the present invention, additives that are part of the animal diet and that fulfill the function of improving the animals' daily weight gain (GDP), as well as the factor of growth, are called "promoters or growth stimulants" food conversion In the present invention, promoters or stimulants of Growth can be administered in different ways, whether injected, in implants or as an additive in animal feed or feed. Administration as an additive in the food or feed is preferred. In the present invention, the effect on growth is measured as an increase in biomass.
A los efectos de la presente invención, el término ácido orgánico se refiere a compuestos que contienen en su fórmula uno o más grupos carboxílicos (-COOH), generadores de protones, que pueden tener además diferentes grupos funcionales tales como hidroxiácidos, cetoácidos, ácidos aromáticos, compuestos heterocíclicos, así como amidas y lactonas. Los ácidos orgánicos utilizados en la presente invención son preferentemente ácidos grasos volátiles, preferentemente de cadena corta y entre los que se pueden seleccionar: ácido butírico, ácido propiónico, ácido fórmico, ácido láctico, ácido cítrico, ácido láurico, ácido cúprico, ácido caprílico, ácido caproico, ácido acético, entre otros. Las proporciones en las que se encuentra el ácido orgánico en el aditivo para alimentación animal descrito en la presente invención, suelen variar entre un 30 y un 70% en peso de producto total húmedo, siendo la proporción preferida de un 50%. For the purposes of the present invention, the term "organic acid" refers to compounds that contain in its formula one or more carboxylic groups (-COOH), proton generators, which may also have different functional groups such as hydroxy acids, keto acids, aromatic acids , heterocyclic compounds, as well as amides and lactones. The organic acids used in the present invention are preferably volatile fatty acids, preferably short chain and from which can be selected: butyric acid, propionic acid, formic acid, lactic acid, citric acid, lauric acid, cupric acid, caprylic acid, caproic acid, acetic acid, among others. The proportions in which the organic acid is found in the animal feed additive described in the present invention, usually vary between 30 and 70% by weight of total wet product, the preferred proportion being 50%.
En el contexto de la presente invención, "probiótico", se refiere a cualquier tipo de microorganismo viable aplicado a un huésped animal u hombre, y que afecta beneficiosamente al huésped, debido a sus efectos beneficiosos, en la salud o en el aumento de la resistencia a enfermedades, que éste pueda tener sobre su consumidor. Los probióticos pueden exhibir una o más de las características siguientes, no limitantes: no patógenos o no tóxicos para el huésped; están presentes como células viables, capaces de sobrevivir en el medio intestinal (por ejemplo, a bajo pH y a los ácidos y las secreciones gastrointestinales), adherencia a las células epiteliales, particularmente a las células epiteliales del tracto gastrointestinal, actividad microbicida o microbiostática o efecto hacia las bacterias patógenas; actividad anticancerígena; actividad de modulación inmune; actividad moduladora de la actividad hacia la flora endógena; mejoramiento de la salud del tracto urogenital; actividad antiséptica en o alrededor de las heridas; reducción de la diarrea; reducción de las reacciones alérgicas; reducción en la enterocolitis necrotizante neonatal; reducción en la enfermedad inflamatoria intestinal y reducción de la permeabilidad intestinal. In the context of the present invention, "probiotic" refers to any type of viable microorganism applied to an animal or human host, and which beneficially affects the host, due to its beneficial effects, on health or on the increase of the resistance to diseases, which it may have on its consumer. Probiotics may exhibit one or more of the following, non-limiting characteristics: non-pathogenic or non-toxic to the host; they are present as viable cells, capable of surviving in the intestinal environment (for example, at low pH and acids and gastrointestinal secretions), adhesion to epithelial cells, particularly to epithelial cells of the gastrointestinal tract, microbicidal or microbiostatic activity or effect towards pathogenic bacteria; anticancer activity; immune modulation activity; activity modulating the activity towards the endogenous flora; improvement of the health of the urogenital tract; antiseptic activity in or around wounds; diarrhea reduction; reduction of allergic reactions; reduction in neonatal necrotizing enterocolitis; reduction in inflammatory bowel disease and reduction of intestinal permeability.
A efectos de la presente invención, el término "viable" se refiere a un microorganismo vivo capaz de reproducirse y/o de colonizar. Tal como se utiliza en el presente documento, las formas singulares "un", "un", y "el" incluyen referencia plural a menos que el contexto indique claramente otra cosa. For the purposes of the present invention, the term "viable" refers to a living microorganism capable of reproducing and / or colonizing. As used herein, the singular forms "a", "a", and "the" include plural reference unless the context clearly indicates otherwise.
Del mismo modo, las palabras "comprender" y "comprende" deben ser interpretados de manera inclusiva y no exclusiva, abarcando, recíprocamente, los términos "consistir" y "consiste". Similarly, the words "understand" and "understand" must be interpreted in an inclusive and non-exclusive manner, encompassing, reciprocally, the terms "consist" and "consist."
Descripción de las figuras Figura 1. Biomasa del camarón Litopenaeus vannamei de aproximadamente 0.85 g de peso, analizada cada 10 días, durante un periodo total de 60 días. Los camarones fueron alimentados con el alimento estándar al que se añadieron los diferentes aditivos de la invención a la concentración de 2g/Kg dieta estándar: ECOBI OL que contiene el probiotico CECT 5940 (primera columna-barra cuadriculada), o ECOBIOL PLUS que contiene el probiotico CECT 5940+BP70 (segunda columna-barra blanca), o ECOBIOL SUPER que contiene la combinación de los probioticos CECT 5940+CECT 953+BP70 (tercera columna-barra negra) o exclusivamente la dieta estándar (grupo control) (cuarta columna-barra rayada). En el eje X se muestra el tiempo expresado en días y en el eje Y la biomasa expresada en gramos. * p<0.05 vs control. Description of the figures Figure 1. Biomass of the Litopenaeus vannamei shrimp weighing approximately 0.85 g, analyzed every 10 days, for a total period of 60 days. The shrimp were fed with the standard food to which the different additives of the invention were added to the concentration of 2g / Kg standard diet: ECOBI OL containing the probiotic CECT 5940 (first column-grid bar), or ECOBIOL PLUS containing the CECT 5940 + BP70 probiotic (second column-white bar), or ECOBIOL SUPER containing the combination of CECT 5940 + CECT 953 + BP70 probiotics (third column-black bar) or exclusively the standard diet (control group) (fourth column- striped bar). The time expressed in days is shown on the X axis and the biomass expressed in grams on the Y axis. * p <0.05 vs control.
Figura 2. Porcentaje de supervivencia de Litopenaeus vannamei de aproximadamente 0.85 g de peso, analizado cada 10 días, durante un periodo total de 60 días alimentando a los camarones con una dieta estándar a la que se añadieron los diferentes aditivos de la invención a la concentración de 2g/Kg dieta estándar: ECOBIOL que contiene el probiotico CECT 5940 (línea discontinua con rombo), o ECOBIOL PLUS que contiene el probiotico CECT 5940+BP70 (línea continua con círculo) , o ECOBIOL SU PER que contiene la combinación de los probioticos CECT 5940+CECT 953+BP70 (línea discontinua con triángulo) o exclusivamente la dieta estándar (línea continua con cuadrado). En el eje X se muestra el tiempo expresado en días y en el ej e Y la supervivencia expresada en forma de porcentaje. * p<0.05 vs control. Figure 2. Litopenaeus vannamei survival percentage of approximately 0.85 g of weight, analyzed every 10 days, for a total period of 60 days feeding shrimp with a standard diet to which the different additives of the invention were added to the concentration of 2g / Kg standard diet: ECOBIOL containing the probiotic CECT 5940 (broken line with rhombus), or ECOBIOL PLUS containing the probiotic CECT 5940 + BP70 (continuous line with circle), or ECOBIOL SU PER containing the combination of probiotics CECT 5940 + CECT 953 + BP70 (dashed line with triangle) or exclusively the standard diet (continuous line with square). The time expressed in days is shown on the X axis and on the Y and Y the survival expressed as a percentage. * p <0.05 vs control.
Figura 3. Factor de conversión alimenticia (gramos de alimento por gramo de biomasa cosechada) de Litopenaeus vannamei de aproximadamente 0.85 g de peso, al final de los 60 días del cultivo, alimentados con su dieta estándar más los aditivos descritos en la invención, ECOBIOL que contiene el probiotico CECT 5940, o ECOBIOL PLUS que contiene el probiotico CECT 5940+ BP70, o ECOB I O L SU PE R q ue contiene la combinación de los probioticos CECT 5940+CECT 953+BP70 o exclusivamente la dieta estándar (grupo control). Figure 3. Food conversion factor (grams of food per gram of biomass harvested) of Litopenaeus vannamei of approximately 0.85 g of weight, at the end of the 60 days of the crop, fed with its standard diet plus the additives described in the invention, ECOBIOL containing the CECT 5940 probiotic, or ECOBIOL PLUS containing the CECT 5940+ BP70 probiotic, or ECOB IOL SU PE R which contains the combination of the probiotics CECT 5940 + CECT 953 + BP70 or exclusively the standard diet (control group).
Figura 4. Biomasa de Litopenaeus vannamei de aproximadamente 7.0 g de peso, analizada cada 10 días, durante un periodo total de 60 días. Los camarones fueron alimentados con el alimento estándar al que se añadieron los diferentes aditivos de la invención a la concentración de 2g/Kg de dieta estándar: ECOBIOL que contiene el probiotico CECT 5940 (primera columna-barra cuadriculada) , o ECOBIOL PLUS que contiene el probiotico CECT 5940+BP70 (segunda columna-barra blanca), o ECOBIOL SUPER que contiene la combinación de los probioticos CECT 5940+CECT 953+BP70 (tercera columna-barra negra) o exclusivamente la dieta estándar (grupo control) (cuarta columna-barra rayada). En el eje X se muestra el tiempo expresado en días y en el eje Y la biomasa expresada en gramos. * p<0.05. Figura 5. Porcentaje de supervivencia de Litopenaeus vannamei de aproximadamente 7.0 g de peso, analizado cada 10 días, durante un periodo total de 60 días alimentando a los camarones con una dieta estándar a la que se añadieron los diferentes aditivos de la invención a la concentración de 2g/Kg de dieta estándar: ECOBIOL que contiene el probiotico CECT 5940 (línea discontinua con rombo), o ECOBIOL PLUS que contiene el probiotico CECT 5940+BP70 (línea continua con círculo) , o ECOBIOL SU PER que contiene la combinación de los probioticos CECT 5940+CECT 953+BP70 (línea discontinua con triángulo) o exclusivamente la dieta estándar (grupo control) (línea continua con un aspa). En el eje X se muestra el tiempo expresado en días y en el eje Y la supervivencia expresada en forma de porcentaje. Figure 4. Litopenaeus vannamei biomass of approximately 7.0 g weight, analyzed every 10 days, for a total period of 60 days. The shrimp were fed with the standard food to which the different additives of the invention were added to the concentration of 2g / kg of standard diet: ECOBIOL containing the probiotic CECT 5940 (first column-grid bar), or ECOBIOL PLUS containing the CECT 5940 + BP70 probiotic (second column-white bar), or ECOBIOL SUPER containing the combination of CECT 5940 + CECT 953 + BP70 probiotics (third column-black bar) or exclusively the standard diet (control group) (fourth column- striped bar). The time expressed in days is shown on the X axis and the biomass expressed in grams on the Y axis. * p <0.05. Figure 5. Litopenaeus vannamei survival percentage of approximately 7.0 g weight, analyzed every 10 days, for a total period of 60 days feeding shrimp with a standard diet to which the different additives of the invention were added to the concentration of 2g / kg of standard diet: ECOBIOL containing the probiotic CECT 5940 (broken line with rhombus), or ECOBIOL PLUS containing the probiotic CECT 5940 + BP70 (continuous line with circle), or ECOBIOL SU PER containing the combination of CECT 5940 + CECT 953 + BP70 probiotics (dashed line with triangle) or exclusively the standard diet (control group) (continuous line with a cross). The time expressed in days is shown on the X axis and the survival expressed as a percentage on the Y axis.
Figura 6. Factor de conversión alimenticia (gramos de alimento por gramo de biomasa cosechada) de Litopenaeus vannamei de aproximadamente 7.0 g de peso, al final de los 60 días del cultivo, alimentados con su dieta estándar más los aditivos descritos en la invención, a la concentración de 2g/Kg de dieta estándar: ECOBIOL que contiene el probiotico CECT 5940, o ECOBIOL PLUS que contiene el probiotico CECT 5940+BP70 o ECOBIOL SUPER que contiene la combinación de los probioticos CECT 5940+CECT 953+BP70 o exclusivamente la dieta estándar (grupo control). Figure 6. Food conversion factor (grams of food per gram of harvested biomass) of Litopenaeus vannamei of approximately 7.0 g of weight, at the end of the 60 days of the crop, fed with its standard diet plus the additives described in the invention, to the concentration of 2g / Kg of standard diet: ECOBIOL containing the probiotic CECT 5940, or ECOBIOL PLUS containing the probiotic CECT 5940 + BP70 or ECOBIOL SUPER containing the combination of the probiotics CECT 5940 + CECT 953 + BP70 or exclusively the diet standard (control group).
Figura 7. Respuesta de la actividad enzimática digestiva en los hepatopáncreas del camarón Litopenaeus vannamei, ante el estímulo de dietas conteniendo los diferentes tipos de probioticos: ECOBIOL que contiene el probiotico CECT 5940 (línea discontinua con rombo), o ECOBIOL PLUS que contiene el probiotico CECT 5940+BP70 (línea continua con círculo), o ECOBIOL SUPER que contiene la combinación de los probióticos CECT 5940+CECT 953+BP70 (línea discontinua con triángulo) o exclusivamente la dieta estándar (grupo control) (línea continua con cuadrado). A tiempo 0 los camarones aún no recibían el ali mento; 1 , 2, 3, 4 y 5h corresponden al tiempo después de que los camarones recibieron el alimento. (a)= Lipasas, (b)= Proteasas, (c) Amilasas y (d)= Quimiotripsinas. En el eje X se muestra el tiempo expresado en horas y en el eje Y se muestra la actividad enzimática específica expresada como U/mg proteína. Figura 8. Estudio del crecimiento de la Tilapia del Nilo Oreochromis niloticus (media±DE) alimentada con diferentes concentraciones del aditivo de la invención ECOBIOL que comprende el probiotico B. amyloliquefaciens CECT 5940. G1 : grupo control alimentado con una dieta basal. G2 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x109 u.f.c/kg. G3 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x107 u.f.c/kg. (A) Las barras indican el peso corporal inicial (IBW), el peso corporal final después de 30 días (FBW1), el peso corporal final después de 60 días (FBW2), aumento de peso después de 30 días (WG1), y el aumento de peso después de 60 días (WG2 ). (B) La figura muestra la tasa de crecimiento específico (SGR) de cada uno de los grupos de estudio en los dos meses del estudio. (C) La figura muestra la relación de eficacia proteica (PER) para cada uno de los grupos de estudio. Figure 7. Response of the digestive enzyme activity in the hepatopancreas of the shrimp Litopenaeus vannamei, given the stimulation of diets containing the different types of probiotics: ECOBIOL containing the probiotic CECT 5940 (dashed line with rhombus), or ECOBIOL PLUS containing the probiotic CECT 5940 + BP70 (continuous line with circle), or ECOBIOL SUPER containing the combination of the probiotics CECT 5940 + CECT 953 + BP70 (dashed line with triangle) or exclusively the standard diet (control group) (continuous line with square). In time 0 the shrimp still did not receive the food; 1, 2, 3, 4 and 5h correspond to the time after the shrimp received the food. (a) = Lipases, (b) = Proteases, (c) Amylases and (d) = Chymotrypsins. The time expressed in hours is shown on the X axis and the specific enzymatic activity expressed as U / mg protein is shown on the Y axis. Figure 8. Study of the growth of Nile Tilapia Oreochromis niloticus (mean ± SD) fed with different concentrations of the additive of the invention ECOBIOL comprising the probiotic B. amyloliquefaciens CECT 5940. G1: control group fed with a basal diet. G2 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 9 cfu / kg. G3 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 7 cfu / kg. (A) The bars indicate the initial body weight (IBW), the final body weight after 30 days (FBW1), the final body weight after 60 days (FBW2), weight gain after 30 days (WG1), and Weight gain after 60 days (WG2). (B) The figure shows the specific growth rate (SGR) of each of the study groups in the two months of the study. (C) The figure shows the protein efficacy ratio (PER) for each of the study groups.
Figura 9. Morfología intestinal de la Tilapia del Nilo O. niloticus después de 2 meses alimentados con el probiotico de la invención ECOBIOL (β. amyloliquefaciens CECT 5940). Figure 9. Intestinal morphology of Nile Tilapia O. niloticus after 2 months fed with the probiotic of the invention ECOBIOL (β. Amyloliquefaciens CECT 5940).
(A) Fotografía de una sección transversal de la parte proximal del intestino teñidas con hematoxilina&Eosina (H&E) donde se muestra la altura de plegado (flechas dobles), las células secretoras de moco (cabezas de flecha) y los linfocitos intraepiteliales (I EL) (flechas). Barra de escala: 50 μηι. (B) La figura muestra la altura de las vellosidades (media ± DE) en las partes proximal, medio y distal del intestino. El asterisco (*) indica una altura de la vellosidad significativamente mayor en la parte proximal del intestino grueso respecto a otras partes del intestino, dentro del mismo grupo. G1 : grupo control alimentado con una dieta basal. G2 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x109 u.f.c/kg. G3 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x107 u.f.c/kg. Una sección transversal de la parte distal del intestino manchado por la tinción de azul alcián mostró pocas células secretoras de moco (flecha) en el grupo de control (C) y numerosas células secretoras de moco en el grupo suplementado con el probiotico ECOBIOL (β. amyloliquefaciens CECT 5940) (D). Barra de escala: 50 μηι. (E) La figura muestra el número de células secretoras de moco (media ± DE) en las partes proximal, media y distal del intestino. (F) Las barras indican el número de IEL (media ± DE) en las partes proximal, media y distal del intestino. Figura 10. Parámetros hematológicos de la Tilapia del Nilo O. niloticus alimentados con el aditivo de la invención ECOBIOL que contiene el probiotico B. amyloliquefaciens CECT 5940), durante 2 meses. (A) Photograph of a cross-section of the proximal part of the intestine stained with hematoxylin & Eosin (H&E) showing the height of folding (double arrows), mucus-secreting cells (arrowheads) and intraepithelial lymphocytes (I EL) (arrows). Scale bar: 50 μηι. (B) The figure shows the height of the villi (mean ± SD) in the proximal, middle and distal parts of the intestine. The asterisk (*) indicates a significantly greater height of hairiness in the proximal part of the large intestine compared to other parts of the intestine, within the same group. G1: control group fed a basal diet. G2 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 9 cfu / kg. G3 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 7 cfu / kg. A cross section of the distal part of the intestine stained by staining of alcian blue showed few mucus-secreting cells (arrow) in the control group (C) and numerous mucus-secreting cells in the group supplemented with the probiotic ECOBIOL (β. amyloliquefaciens CECT 5940) (D). Scale bar: 50 μηι. (E) The figure shows the number of mucus-secreting cells (mean ± SD) in the proximal, middle and distal parts of the intestine. (F) The bars indicate the number of IEL (mean ± SD) in the proximal, middle and distal parts of the intestine. Figure 10. Hematological parameters of Nile Tilapia O. niloticus fed with the additive of the invention ECOBIOL containing the probiotic B. amyloliquefaciens CECT 5940), for 2 months.
(A) recuento de glóbulos rojos. (B) Contenido de Hemoglobina. (C) %PCV (Packed Cell Volume en sus siglas en inglés, Hematocrito). (D) Recuento de glóbulos blancos. (E) Nivel de glucosa. (F) Concentración de proteínas séricas (proteínas totales, albúmina y globulina). G1 : grupo control alimentado con una dieta basal. G2 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x109 u.f.c/kg. G3 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x107 u.f.c/kg. (A) red blood cell count. (B) Hemoglobin content. (C)% PCV (Packed Cell Volume). (D) White blood cell count. (E) Glucose level. (F) Concentration of serum proteins (total proteins, albumin and globulin). G1: control group fed a basal diet. G2 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 9 cfu / kg. G3 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 7 cfu / kg.
Figura 11. Constituyentes del cuerpo de la Tilapia del Nilo O. niloticus alimentados con diferentes concentraciones del aditivo ECOBIOL que contiene el probiotico B. amyloliquefaciens CECT 5940, durante 2 meses. Las barras indican el % de proteína cruda (A), % de lípidos crudos (B), contenido de ceniza (polvo o impurezas) (C) y % de humedad (D). G1 : grupo control alimentado con una dieta basal. G2 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x109 u.f.c/kg. G3 grupo alimentado con una dieta basal suplementada con el probiotico B. amyloliquefaciens CECT 5940 a una concentración de esporas de 1x107 u.f.c/kg. Figure 11. Constituents of the body of Nile Tilapia O. niloticus fed with different concentrations of the ECOBIOL additive containing the probiotic B. amyloliquefaciens CECT 5940, for 2 months. The bars indicate% crude protein (A),% crude lipids (B), ash content (dust or impurities) (C) and% moisture (D). G1: control group fed a basal diet. G2 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 9 cfu / kg. G3 group fed a basal diet supplemented with the probiotic B. amyloliquefaciens CECT 5940 at a spore concentration of 1x10 7 cfu / kg.
Figura 12. Biomasa (expresada en Kg) de la trucha arco iris Oncorhynchus mykiss analizada a los 60 días de comenzar el tratamiento. El diseño experimental se explica en el Ejemplo 6. Cada uno de los tratamientos analizados comprende: Figure 12. Biomass (expressed in Kg) of the rainbow trout Oncorhynchus mykiss analyzed 60 days after starting treatment. The experimental design is explained in Example 6. Each of the treatments analyzed comprises:
T1 : 43% de harina de pescado (HP) y 25 % de torta de soya (TS) T1: 43% fishmeal (HP) and 25% soy cake (TS)
T2: 29 % de HP y 50% de TS T3: HP+ECOBIOL T2: 29% HP and 50% TS T3: HP + ECOBIOL
T4: TS+ECOBIOL T4: TS + ECOBIOL
T5: HP+BP-70 T5: HP + BP-70
T6: TS+BP-70 T6: TS + BP-70
T7: HP+ECOBIOL+BP-70 T7: HP + ECOBIOL + BP-70
T8: TS+ ECOBIOL+BP-70 T8: TS + ECOBIOL + BP-70
Figura 13. Longitud (expresada en cm) de la trucha arco iris O.mykiss analizada a los 60 días de comenzar el tratamiento. El diseño experimental se explica en el Ejemplo 6. Cada uno de los tratamientos analizados comprende: Figure 13. Length (expressed in cm) of the rainbow trout O.mykiss analyzed 60 days after starting treatment. The experimental design is explained in Example 6. Each of the treatments analyzed comprises:
T1 : 43% de harina de pescado (HP) y 25 % de torta de soya (TS)  T1: 43% fishmeal (HP) and 25% soy cake (TS)
T2: 29 % de HP y 50% de TS  T2: 29% HP and 50% TS
T3: HP+ECOBIOL  T3: HP + ECOBIOL
T4: TS+ECOBIOL  T4: TS + ECOBIOL
T5: HP+BP-70 T5: HP + BP-70
T6: TS+BP-70  T6: TS + BP-70
T7: HP+ECOBIOL+BP-70  T7: HP + ECOBIOL + BP-70
T8: TS+ ECOBIOL+BP-70 Figura 14. Consumo de alimento (expresado en Kg) de la trucha arco iris O.mykiss analizada a los 60 días de comenzar el tratamiento. El diseño experimental se explica en el Ejemplo 6. Cada uno de los tratamientos analizados comprende:  T8: TS + ECOBIOL + BP-70 Figure 14. Food consumption (expressed in Kg) of the rainbow trout O.mykiss analyzed 60 days after starting treatment. The experimental design is explained in Example 6. Each of the treatments analyzed comprises:
T1 : 43% de harina de pescado (HP) y 25 % de torta de soya (TS)  T1: 43% fishmeal (HP) and 25% soy cake (TS)
T2: 29 % de HP y 50% de TS  T2: 29% HP and 50% TS
T3: HP+ECOBIOL T3: HP + ECOBIOL
T4: TS+ECOBIOL  T4: TS + ECOBIOL
T5: HP+BP-70  T5: HP + BP-70
T6: TS+BP-70  T6: TS + BP-70
T7: HP+ECOBIOL+BP-70  T7: HP + ECOBIOL + BP-70
T8: TS+ ECOBIOL+BP-70 T8: TS + ECOBIOL + BP-70
Figura 15. Conversión del alimento (C.A.) de la trucha arco iris O.mykiss analizada a los 60 días de comenzar el tratamiento. El diseño experimental se explica en el Ejemplo 6. Cada uno de los tratamientos analizados comprende: Figure 15. Conversion of the food (C.A.) of the rainbow trout O.mykiss analyzed 60 days after starting treatment. The experimental design is explained in Example 6. Each of the treatments analyzed comprises:
T1 : 43% de harina de pescado (HP) y 25 % de torta de soya (TS) T1: 43% fishmeal (HP) and 25% soy cake (TS)
T2: 29 % de HP y 50% de TS T3: HP+ECOBIOL T2: 29% HP and 50% TS T3: HP + ECOBIOL
T4: TS+ECOBIOL T4: TS + ECOBIOL
T5: HP+BP-70 T5: HP + BP-70
T6: TS+BP-70 T6: TS + BP-70
T7: HP+ECOBIOL+BP-70 T7: HP + ECOBIOL + BP-70
T8: TS+ ECOBIOL+BP-70 T8: TS + ECOBIOL + BP-70
Figura 16. Supervivencia (expresada en forma de %) de la trucha arco iris O.mykiss analizada a los 60 días de comenzar el tratamiento. El diseño experimental se explica en el Ejemplo 6. Cada uno de los tratamientos analizados comprende: Figure 16. Survival (expressed as a%) of the rainbow trout O.mykiss analyzed 60 days after starting treatment. The experimental design is explained in Example 6. Each of the treatments analyzed comprises:
T1 : 43% de harina de pescado (HP) y 25 % de torta de soya (TS)  T1: 43% fishmeal (HP) and 25% soy cake (TS)
T2: 29 % de HP y 50% de TS  T2: 29% HP and 50% TS
T3: HP+ECOBIOL  T3: HP + ECOBIOL
T4: TS+ECOBIOL  T4: TS + ECOBIOL
T5: HP+BP-70 T5: HP + BP-70
T6: TS+BP-70  T6: TS + BP-70
T7: HP+ECOBIOL+BP-70  T7: HP + ECOBIOL + BP-70
T8: TS+ ECOBIOL+BP-70 Descripción detallada de la invención  T8: TS + ECOBIOL + BP-70 Detailed description of the invention
Un aspecto de la presente invención se refiere a un aditivo para alimentación de animales acuáticos que comprende la combinación de, al menos, dos especies pertenecientes al género Bacillus, seleccionadas de entre B. amyloliquefaciens y Bacillus cereus. One aspect of the present invention relates to an additive for feeding aquatic animals comprising the combination of at least two species belonging to the genus Bacillus, selected from B. amyloliquefaciens and Bacillus cereus.
En una realización preferida, el aditivo de la invención comprende las cepas CECT 5940 de Bacillus amyloliquefaciens y la cepa CECT 953 de Bacillus cereus. In a preferred embodiment, the additive of the invention comprises the CECT 5940 strains of Bacillus amyloliquefaciens and the CECT 953 strain of Bacillus cereus.
En otra realización preferida de la invención, el aditivo para alimentación de animales acuáticos puede comprender además otros probióticos seleccionados de entre cualquiera de los siguientes géneros: Bifidobacterium, Bacteroides, Clostridium, Fusobacterium, Melissococcus, Propionibacterium, Streptococcus, Enterococcus, Lactococcus, Staphylococcus, Peptostrepococcus, Bacillus, Pediococcus, Micrococcus, Leuconostoc, Weissella, Aerococcus, Oenococcus y Lactobacillus. En realizaciones preferidas, los probioticos comprenden al menos una cepa adecuada o subespecie de entre: Enterococcus, Streptococcus, Lactobacillus, Lactococcus, Bifidobacterium y Pediococcus y/o combinaciones de las mismas. En una realización más preferida de la invención la cepa se seleccionan del género Pediococcus, preferentemente de la especie Pediococcus acidilactici, y en una real ización más preferida, el probiótico más preferido es Pediococcus acidilactici cepa CNCM MA 18/5 M, depositado en la Colección Nacional de Cultivos de Microorganismos (CNCM) del Instituto Pasteur de París. Los aditivos descritos en la presente invención incluyen probioticos en una cantidad adecuada para mejorar el sistema inmunológico, para aumentar los efectos beneficiosos de los probioticos y/o para incrementar la biomasa de los animales y/o extender la vida de los mismos. En general, los aditivos alimenticios comprenden aproximadamente de 105 a 1010 UFC/g de pienso para cada uno de los probioticos utilizados, siendo preferida una concentración de aproximadamente 106 UFC/g de pienso, de cada uno de los probioticos utilizados. In another preferred embodiment of the invention, the additive for feeding aquatic animals may further comprise other probiotics selected from any of the following genera: Bifidobacterium, Bacteroides, Clostridium, Fusobacterium, Melissococcus, Propionibacterium, Streptococcus, Enterococcus, Lactococcus, Staphylococcus, Peptostcococus, , Bacillus, Pediococcus, Micrococcus, Leuconostoc, Weissella, Aerococcus, Oenococcus and Lactobacillus. In preferred embodiments, the probiotics comprise at least one suitable strain or subspecies from among: Enterococcus, Streptococcus, Lactobacillus, Lactococcus, Bifidobacterium and Pediococcus and / or combinations thereof. In a more preferred embodiment of the invention the strain is selected from the genus Pediococcus, preferably from the species Pediococcus acidilactici, and in a more preferred embodiment, the most preferred probiotic is Pediococcus acidilactici strain CNCM MA 18/5 M, deposited in the Collection National Crops of Microorganisms (CNCM) of the Pasteur Institute in Paris. The additives described in the present invention include probiotics in an amount suitable to improve the immune system, to increase the beneficial effects of the probiotics and / or to increase the biomass of the animals and / or extend their life. In general, food additives comprise approximately 10 5 to 10 10 CFU / g of feed for each of the probiotics used, with a concentration of approximately 10 6 CFU / g of feed being preferred, of each of the probiotics used.
El experto en la técnica puede determinar la cantidad apropiada de los probioticos que se añade al aditivo de la invención. Dichos factores que pueden tenerse en cuenta son el promedio de consumo de determinados tipos de composiciones de diferentes animales, si el animal que tiene la intención de ingerir los suplementos dietéticos tiene algún problema de salud en particular, el bienestar o las necesidades nutricionales, o sufre de una enfermedad o trastorno, la edad, sexo, tamaño o especie del animal. Las concentraciones de los probioticos para ser añadidos al aditivo de la invención pueden calcularse sobre la base de los requerimientos de energía y nutrientes del animal. The person skilled in the art can determine the appropriate amount of probiotics that is added to the additive of the invention. These factors that can be taken into account are the average consumption of certain types of compositions of different animals, if the animal that intends to ingest dietary supplements has a particular health problem, well-being or nutritional needs, or suffers of a disease or disorder, the age, sex, size or species of the animal. The concentrations of the probiotics to be added to the additive of the invention can be calculated based on the energy and nutrient requirements of the animal.
En otra realización preferida de la invención el aditivo comprende además al menos una sal de un ácido orgánico. En otra realización preferida, los ácidos orgánicos se seleccionan de entre cualquiera de los siguientes: butírico, propiónico, fórmico, láctico, cítrico, láurico, cúprico, caprílico, caproico o acético. In another preferred embodiment of the invention the additive further comprises at least one salt of an organic acid. In another preferred embodiment, the organic acids are selected from any of the following: butyric, propionic, formic, lactic, citric, lauric, cupric, caprylic, caproic or acetic.
En otra realización más preferida de la invención, las sales de los ácidos orgánicos se seleccionan de entre cualquiera de la lista: sódica, cálcica, cúprica o potásica. Las proporciones en las que se encuentra la sal del ácido orgánico en el aditivo para alimentación animal descrito en la presente invención, suele variar entre un 30 y un 70% en peso del aditivo final húmedo, siendo la proporción preferida de un 60%. In another more preferred embodiment of the invention, the salts of the organic acids are selected from any of the list: sodium, calcium, cupric or potassium. The proportions in which the organic acid salt is found in the additive for animal feed described in the present invention, usually varies between 30 and 70% by weight of the final wet additive, the preferred proportion being 60%.
En otra realización aún más preferida, la sal del ácido orgánico que comprende el aditivo de la invención es la sal sódica del ácido butírico (butirato sódico), aunque puede ser utilizada cualquiera de las sales de los ácidos descritos previamente. In another even more preferred embodiment, the organic acid salt comprising the additive of the invention is the sodium salt of butyric acid (sodium butyrate), although any of the salts of the acids described previously may be used.
En otra realización preferida el aditivo de la invención se caracteriza por que comprende una combinación de los probióticos CECT 5940 de B. amyloliquefaciens y CECT 953 de B. cereus junto con sal sódica del ácido butírico. In another preferred embodiment the additive of the invention is characterized in that it comprises a combination of the CECT 5940 probiotics of B. amyloliquefaciens and CECT 953 of B. cereus together with sodium salt of butyric acid.
Los aditivos de la invención, pueden comprender adicionalmente también sustancias tales como: minerales, vitaminas, proteínas, aminoácidos, colorantes, conservantes, etc. Ejemplos no limitantes de minerales incluyen por ejemplo: calcio, fósforo, potasio, sodio, hierro, cloro, cobre, zinc, magnesio, manganeso, selenio, etc. Ejemplos no limitantes de vitaminas incluyen por ejemplo: Vitamina A, diferentes tipos de Vitamina B (niacina, acido pantoténico, ácido fólico, biotina) Vitamina D y Vitamina K. The additives of the invention may additionally also comprise substances such as: minerals, vitamins, proteins, amino acids, dyes, preservatives, etc. Non-limiting examples of minerals include for example: calcium, phosphorus, potassium, sodium, iron, chlorine, copper, zinc, magnesium, manganese, selenium, etc. Non-limiting examples of vitamins include for example: Vitamin A, different types of Vitamin B (niacin, pantothenic acid, folic acid, biotin) Vitamin D and Vitamin K.
Otro de los objetos descritos en la presente invención se refiere al uso de los aditivos descritos en el presente documento en la cría de animales acuáticos, como promotores del crecimiento de dichos animales, siendo capaces de favorecer el factor de conversión del alimento, así como la actividad específica de enzimas digestivas, preferentemente de lipasas, proteasas, amilasas y quimiotripsinas. Another of the objects described in the present invention relates to the use of the additives described herein in the breeding of aquatic animals, as growth promoters of said animals, being able to favor the food conversion factor, as well as the specific activity of digestive enzymes, preferably of lipases, proteases, amylases and chymotrypsins.
En una realización preferida de la invención, los aditivos descritos aquí se usan para promover la salud y el bienestar de los animales acuáticos. In a preferred embodiment of the invention, the additives described herein are used to promote the health and welfare of aquatic animals.
En otra real ización preferida de la i nvención , los probióticos descritos aquí, preferentemente los probióticos seleccionados entre B. amyloliquefaciens, B. cereus, B. subtilis y B. licheniformis y/o combinaciones de los mismos, se utilizan en la cría de animales acuáticos. In another preferred embodiment of the invention, the probiotics described herein, preferably the probiotics selected from B. amyloliquefaciens, B. cereus, B. subtilis and B. licheniformis and / or combinations thereof, are used in animal husbandry aquatic
En otra realización más preferida, los probióticos utilizados para la cría de animales acuáticos son preferentemente el probiótico CECT 5940 de B. amyloliquefaciens y el probiótico CECT 953 de B. cereus. En otra realización más preferida, los probióticos utilizados para la cría de animales acuáticos se caracterizan por que además puede incluir un probiótico adicional del género Pediococcus, preferentemente la especie Pediococcus acidilactici y más preferentemente la cepa CNCM MA 18/5 M, depositado en la Colección Nacional de Cultivos de Microorganismos (CNCM) del Instituto Pasteur de París. In another more preferred embodiment, the probiotics used for the breeding of aquatic animals are preferably the CECT 5940 probiotic of B. amyloliquefaciens and the CECT 953 probiotic of B. cereus. In another more preferred embodiment, the probiotics used for the breeding of aquatic animals are characterized in that they can also include an additional probiotic of the genus Pediococcus, preferably the species Pediococcus acidilactici and more preferably the strain CNCM MA 18/5 M, deposited in the Collection National Crops of Microorganisms (CNCM) of the Pasteur Institute in Paris.
En otra realización más preferida de la invención, los probióticos utilizados para la cría de animales acuáticos se caracterizan por que además comprenden al menos una sal de un ácido orgánico, encontrándose dicha sal del ácido orgánico preferentemente en una proporción de entre un 30-70% en peso húmedo, siendo más preferible una proporción del 60%. In another more preferred embodiment of the invention, the probiotics used for the breeding of aquatic animals are characterized in that they further comprise at least one salt of an organic acid, said salt of the organic acid being preferably in a proportion of between 30-70% in wet weight, a proportion of 60% being more preferable.
En otra realización más preferida de la invención, los ácidos orgánicos se seleccionan de entre cualquiera de los siguientes: butírico, propiónico, fórmico, láctico, cítrico, láurico, cúprico, caprílico, caproico o acético. In another more preferred embodiment of the invention, the organic acids are selected from any of the following: butyric, propionic, formic, lactic, citric, lauric, cupric, caprylic, caproic or acetic.
En otra realización más preferida de la invención, las sales de ácidos orgánicos se seleccionan de entre cualquiera de la lista: sódica, cálcica, cúprica o potásica. En otra realización más preferida aún de la invención, los probióticos utilizados para la cría de animales acuáticos se caracterizan por que la sal del ácido orgánico es la sal sódica del ácido butírico. In another more preferred embodiment of the invention, the salts of organic acids are selected from any of the list: sodium, calcium, cupric or potassium. In another even more preferred embodiment of the invention, the probiotics used for the breeding of aquatic animals are characterized in that the organic acid salt is the sodium salt of butyric acid.
En otra realización más preferida de la invención, los probióticos utilizados para la cría de animales acuáticos comprenden una combinación de los probióticos CECT 5940 de B. amyloliquefaciens y CECT 953 de B. cereus junto con sal sódica del ácido butírico. In another more preferred embodiment of the invention, the probiotics used for the breeding of aquatic animals comprise a combination of the CECT 5940 probiotics of B. amyloliquefaciens and CECT 953 of B. cereus together with sodium salt of butyric acid.
En otra realización preferida de la presente invención, los probióticos utilizados para la cría de animales acuáticos, además también presentan la capacidad de modular la respuesta inmune y ejercer un efecto bactericida frente a microorganismos patógenos. Por otro lado, tal y como se demuestra en la presente invención, los probióticos descritos aquí presentan además, la capacidad de ejercer una acción biorremediadora, ayudando por tanto al mantenimiento del ambiente de las superficies en las que se localizan, preferentemente gracias a la secreción de exo-enzimas que descomponen la materia orgánica y disminuyen la DQO (demanda química de oxígeno) parámetro aceptado como indicador de calidad de agua. En otra realización preferida de la invención, los animales acuáticos se seleccionan de entre cualquiera de la lista: moluscos, crustáceos, tilapia, dorada, lubina y salmónidos, siendo preferidos los crustáceos, preferentemente los camarones. Todos los porcentajes expresados aquí son en peso de la composición de aditivo en base a materia seca a menos que específicamente se indique lo contrario. In another preferred embodiment of the present invention, the probiotics used for the breeding of aquatic animals also have the ability to modulate the immune response and exert a bactericidal effect against pathogenic microorganisms. On the other hand, as demonstrated in the present invention, the probiotics described herein also have the ability to exert a bioremediating action, thus helping to maintain the environment of the surfaces on which they are located, preferably thanks to secretion. of exo-enzymes that break down organic matter and decrease the COD (chemical oxygen demand) accepted parameter as an indicator of water quality. In another preferred embodiment of the invention, aquatic animals are selected from any of the list: mollusks, crustaceans, tilapia, gilthead sea bass, and salmonids, with crustaceans being preferred, preferably shrimp. All percentages expressed herein are by weight of the additive composition based on dry matter unless specifically indicated otherwise.
La invención no se limita a la metodología en particular, los protocolos y reactivos descritos en este documento, ya que pueden variar. Además, la terminología usada aquí es para el propósito de describir las realizaciones particulares solamente y no está destinado a limitar el alcance de la presente invención. The invention is not limited to the particular methodology, protocols and reagents described herein, as they may vary. In addition, the terminology used here is for the purpose of describing particular embodiments only and is not intended to limit the scope of the present invention.
A menos que se defina otra cosa, todos los términos técnicos, científicos y cualquier acrónimo utilizado aquí tiene el mismo significado como se entiende comúnmente por un experto medio en la técnica dentro del campo de la invención. Unless otherwise defined, all technical, scientific and any acronym terms used here have the same meaning as commonly understood by a person skilled in the art within the scope of the invention.
Los ejemplos que se describen a continuación tienen como objetivo ilustrar la presente invención, pero sin limitar el alcance de la misma. Ejemplo 1. Respuesta del crecim iento y supervivencia del camarón blanco Litopenaeus vannamei ali mentado con dieta estándar suplementada con los aditivos de la invención. The examples described below are intended to illustrate the present invention, but without limiting the scope thereof. Example 1. Growth response and survival of the white shrimp Litopenaeus vannamei fed with a standard diet supplemented with the additives of the invention.
Se utilizaron camarones de la especie Litopenaeus vannamei, seleccionados al azar, con un peso promedio de 0.85 g. Dichos camarones fueron previamente aclimatados durante 72 horas en un tanque de 2500 litros de agua marina con 36.0 UPS (unidades prácticas de salinidad), aireación constante (>4.0 mg/l de oxígeno), temperatura controlada (30 a 34°C) y pH de 7.5 a 8.0. Los camarones se cultivaron en acuarios de 10 L, con agua marina y conservando las variables de calidad mencionadas anteriormente. Los ensayos se llevaron a cabo con un total de 8 camarones por acuario con seis replicaciones para cada uno de los aditivos alimenticios utilizados en la presente invención. El experimento tuvo una duración de 60 días, con biometrías cada 10 diez días con el fin de evaluar las tasas de crecimiento, supervivencia y biomasa. La biomasa se refiere a la suma de los pesos individuales de los camarones presentes en cada uno de los tratamientos con los diferentes aditivos dietéticos. Para la elaboración de las dietas se utilizó un alimento/pienso comercial utilizado comúnmente para la alimentación de los camarones con un 35% de proteína el cual fue molido y tamizado a 200 mieras. Los diferentes probióticos fueron agregados en forma de aditivo a la dieta estándar a razón de 2g/Kg de alimento. Una vez incorporado el aditivo a la dieta estándar, la mezcla fue homogenizada y pasada por un molino para carnes y finalmente por un horno de secado a 40°C durante 12 horas. El alimento fue colocado en comederos; el alimento no consumido posterior a las dos horas fue retirado y posteriormente pesado para su análisis. Las cuatro dietas analizadas que contenían los suplementos dietéticos o aditivos descritos en la presente invención se describen en la Tabla l . Shrimp of the species Litopenaeus vannamei, randomly selected, with an average weight of 0.85 g were used. These shrimp were previously acclimatized for 72 hours in a 2500 liter tank of seawater with 36.0 UPS (practical salinity units), constant aeration (> 4.0 mg / l oxygen), controlled temperature (30 to 34 ° C) and pH from 7.5 to 8.0. The shrimp were grown in 10 L aquariums, with sea water and keeping the quality variables mentioned above. The tests were carried out with a total of 8 shrimp per aquarium with six replications for each of the food additives used in the present invention. The experiment lasted 60 days, with biometrics every 10 to 10 days in order to assess growth, survival and biomass rates. Biomass refers to the sum of the individual weights of shrimp present in each of the treatments with the different dietary additives. For the preparation of the diets, a commercial feed / feed commonly used for feeding shrimp with 35% protein was used, which was ground and sieved at 200 microns. The different probiotics were added as an additive to the standard diet at a rate of 2g / kg of food. Once the additive was incorporated into the standard diet, the mixture was homogenized and passed through a meat grinder and finally by a drying oven at 40 ° C for 12 hours. The food was placed in feeders; food not consumed after two hours was removed and subsequently weighed for analysis. The four analyzed diets containing the dietary supplements or additives described in the present invention are described in Table 1.
Tabla 1. Los camarones se alimentaron tres veces al día ad limitum de acuerdo con el siguiente programa de alimentación. Table 1. Shrimp were fed three times a day ad limitum according to the following feeding program.
Figure imgf000020_0001
Figure imgf000020_0001
Por consiguiente, cuando en la presente descripción se habla de alimento en los ensayos llevados a cabo, este término comprende tanto la dieta estándar suministrada a los controles, formada por el alimento comercial arriba indicado, como la mezcla de éste con los diferentes aditivos de la invención. Therefore, when the present description refers to food in the tests carried out, this term includes both the standard diet supplied to the controls, formed by the commercial food indicated above, and the mixture thereof with the different additives of the invention.
Como se ha indicado previamente a lo largo del presente documento, el probiotico ECOBIOL comprende la bacteria B. amyloliquefaciens cepa CECT 5940, el probiotico ECOBIOL PLUS que contiene la bacteria B. amyloliquefaciens cepa CECT 5940 junto con la sal sódica del ácido butírico BP70. Como se ha mencionado previamente, la sal sódica del ácido butírico, específicamente la composición de Norel, S.A. llamada BP-70 está formada, por un 70% en peso húmedo de butirato sódico y un 30% en peso húmedo de grasas vegetales. El 30% de la grasa vegetal protege aproximadamente el 43% del butirato sódico total, así por tanto, el producto BP-70 se puede decir que está formado por un 30% de butirato sódico protegido y por un 40% de butirato sódico sin proteger. El probiótico ECOBIOL SUPER contiene la combinación de las bacterias B. amyloliquefaciens cepa CECT 5940, junto B. cereus cepa 953 y junto con BP-70. As previously indicated throughout the present document, the ECOBIOL probiotic comprises the bacteria B. amyloliquefaciens strain CECT 5940, the probiotic ECOBIOL PLUS containing the bacteria B. amyloliquefaciens strain CECT 5940 together with the sodium salt of the butyric acid BP70. As mentioned previously, the sodium salt of butyric acid, specifically the composition of Norel, SA called BP-70, is made up of 70% by weight of sodium butyrate and 30% by weight of vegetable fats. 30% of vegetable fat protects approximately 43% of total sodium butyrate, so the BP-70 product can be said to be made up of 30% protected sodium butyrate and 40% unprotected sodium butyrate . He ECOBIOL SUPER probiotic contains the combination of bacteria B. amyloliquefaciens strain CECT 5940, together with B. cereus strain 953 and together with BP-70.
El alimento fue agregado a saciedad tres veces al día utilizando comederos. El factor de conversión alimenticia (FCA) , fue calculado en gramos de alimento por gramo de biomasa extraída; utilizando los valores del alimento agregado diariamente, el no consumido y la biomasa de camarón obtenida al final de los 60 días del experimento. El crecimiento y la supervivencia de los camarones fueron evaluadas cada 10 días registrando el peso promedio y el número de camarones respectivamente. The food was added to satiety three times a day using feeders. The food conversion factor (FCA) was calculated in grams of food per gram of biomass extracted; using the values of the food added daily, the unconsumed and the shrimp biomass obtained at the end of the 60 days of the experiment. Shrimp growth and survival were evaluated every 10 days by recording the average weight and the number of shrimp respectively.
Los resultados de crecimiento y supervivencia muestran, como se puede observar en las Figuras 1 y 2 respectivamente, que los camarones ali mentados con la dieta suplementada con el aditivo ECOBIOL SUPER generó diferencias significativas (p<0.05) de peso y supervivencia ya a partir de los 40 días del experimento, con respecto a la dieta control. Como además se puede observar en la Figura 1 , los camarones alimentados con los aditivos ECOBIOL, ECOBIOL PLUS y ECOBIOS SUPER, a los 60 días de tratamiento, muestran un incremento significativo (p<0.05) en su biomasa respecto al grupo control. The results of growth and survival show, as can be seen in Figures 1 and 2 respectively, that shrimp fed with the diet supplemented with the additive ECOBIOL SUPER generated significant differences (p <0.05) in weight and survival, starting from 40 days of the experiment, regarding the control diet. As can also be seen in Figure 1, shrimp fed with the additives ECOBIOL, ECOBIOL PLUS and ECOBIOS SUPER, at 60 days of treatment, show a significant increase (p <0.05) in their biomass with respect to the control group.
Para demostrar si el peso inicial del animal influye en la respuesta al crecimiento y la supervivencia de los camarones alimentados con los diferentes aditivos dietéticos descritos en la invención, se diseñó un experimento con camarones, seleccionados al azar, con un peso promedio de 7.0 g. Como se puede observar en la Figura 4, ya a partir del día 30 de tratamiento, los camarones alimentados con la dieta ECOBIOL SUPER presentaron un incremento significativo en su biomasa con respecto a los camarones alimentados con la dieta control (p<0.05). Por otro lado, tal y como puede observarse en la Figura 5 los camarones alimentados con las dietas conteniendo los aditivos de la invención, mostraron un mayor porcentaje de supervivencia respecto a los animales alimentados exclusivamente con la dieta estándar, grupo control y un mejor factor de conversión del alimento (Figura 6).  To demonstrate whether the initial weight of the animal influences the response to growth and survival of shrimp fed with the different dietary additives described in the invention, an experiment was designed with shrimp, randomly selected, with an average weight of 7.0 g. As can be seen in Figure 4, as of day 30 of treatment, shrimp fed with the ECOBIOL SUPER diet showed a significant increase in their biomass compared to shrimp fed with the control diet (p <0.05). On the other hand, as can be seen in Figure 5, shrimp fed the diets containing the additives of the invention, showed a higher survival rate compared to animals fed exclusively with the standard diet, control group and a better factor of feed conversion (Figure 6).
El aprovechamiento del alimento, analizado como factor de conversión alimenticia, fue mejor en las dietas que contenían los aditivos de la invención (Figuras 3 y 6), lo que indica que los animales tienen mayor disponibilidad de nutrientes para el crecimiento y para la obtención de energía. Esto a largo plazo, se refleja en lograr animales más sanos y con tallas más adecuadas para la comercialización, en un menor tiempo. Por lo tanto, los datos mostrados en la presente invención, ponen de manifiesto que los aditivos descritos funcionan como promotores del crecimiento en animales acuáticos, preferentemente crustáceos, con resultados superiores a los obtenidos con la dieta estándar, sin incluir aditivos. The use of food, analyzed as a food conversion factor, was better in the diets containing the additives of the invention (Figures 3 and 6), indicating that animals have greater availability of nutrients for growth and for obtaining Energy. This in the long term, is reflected in achieving healthier animals and with sizes more suitable for commercialization, in a shorter time. Therefore, the data shown in the present invention show that the described additives function as growth promoters in aquatic animals, preferably crustaceans, with results superior to those obtained with the standard diet, not including additives.
Ejemplo 2. Actividad enzimática digestiva del camarón blanco L. vannamei alimentado con los diferentes aditivos descritos en la invención. Example 2. Digestive enzymatic activity of the white shrimp L. vannamei fed with the different additives described in the invention.
La expresión y actividad de enzimas digestivas es afectada por una serie de factores limitantes como por ejemplo: parámetros físico-químicos del agua (pH, oxígeno, salinidad y temperatura), edad y tamaño del camarón, cambios ontogénicos, ayuno, ingredientes de la dieta, nivel y fuente proteica, nivel y tipo de aglutinantes, aditivos promotores de crecimiento, cantidad y frecuencia de alimentación, ciclos circadianos, ciclo de muda e incluso el agua de cultivo. The expression and activity of digestive enzymes is affected by a series of limiting factors such as: physical-chemical parameters of water (pH, oxygen, salinity and temperature), age and size of shrimp, ontogenetic changes, fasting, diet ingredients , level and protein source, level and type of binders, growth promoting additives, quantity and frequency of feeding, circadian cycles, molting cycle and even the cultivation water.
Para determinar la respuesta de actividad enzimática digestiva ante el estímulo de los diferentes aditivos dietéticos utilizados en la presente invención: ECOBIOL, ECOBIOL PLUS y ECOBIOL SÚPER, se utilizaron camarones juveniles de L vannamei, con un peso promedio de 6 g, los cuales fueron mantenidos en ayuno por 12 horas y previamente seleccionados en estadios de intermuda. La intermuda se conoce como la secuencia de transformaciones comprendidas entre dos mudas (eliminación del antiguo exoesqueleto y la formación de un tegumento nuevo y generalmente de mayor tamaño), en cuyo período se cumple un ciclo completo de modificaciones morfológicas, fisiológicas y bioquímicas, responsables del crecimiento. Las mediciones de dicha actividad enzimática se realizaron en intervalos de una hora, durante un tiempo de 5 horas. To determine the response of digestive enzymatic activity to the stimulation of the different dietary additives used in the present invention: ECOBIOL, ECOBIOL PLUS and ECOBIOL SUPER, juvenile L vannamei shrimp were used, with an average weight of 6 g, which were maintained fasting for 12 hours and previously selected in intermuda stages. The intermuda is known as the sequence of transformations between two molts (elimination of the old exoskeleton and the formation of a new and generally larger tegument), in which period a complete cycle of morphological, physiological and biochemical modifications, responsible for the increase. The measurements of said enzymatic activity were carried out in intervals of one hour, for a time of 5 hours.
La actividad y producción de enzimas digestivas en el hepatopáncreas de los crustáceos se encuentra controlada principalmente por hormonas. El hepatopáncreas, a diferencia del intestino y estómago, presenta una mayor actividad enzimática, sugiriendo la importancia de dicho órgano en la síntesis y secreción de enzimas digestivas. The activity and production of digestive enzymes in the hepatopancreas of crustaceans is mainly controlled by hormones. The hepatopancreas, unlike the intestine and stomach, has a greater enzymatic activity, suggesting the importance of this organ in the synthesis and secretion of digestive enzymes.
Para el análisis de la actividad enzimática digestiva se determinó la actividad proteasa, lipasa, amilasa y quimiotripsinasa, en los extractos enzimáticos preparados mediante la metodología propuesta por Galgani F. (Galgani, F. PhD. Thesis Université dÁix-Marseille //. Etude des proteases digestives de crevettes peneides (Crustácea Decapada) France. 1983) en los hepatopáncreas extraídos de los camarones, a los intervalos indicados previamente y que estaban almacenados, para dicho análisis, a una temperatura de - 48°C. Además se determinó, mediante el método de Bradford la concentración de proteínas presentes en dichos extractos enzimáticos. Para obtener los datos de actividad proteasa presente en los extractos enzimáticos se siguió el método descrito por Hernández C.M. (Hernández, C.M. Crustacean protease characterization biochemical and molecular consideration. Comprehensive summary Ph D Thesis. 1983. Centro de Investigaciones Biológicas del Noroeste, La Paz, B.C.S. México.), usando como sustrato la azocaseína. La actividad lipasa presente en los extractos se determinó de acuerdo a Versaw W.K. et al. (Versaw, W.K. et al. Journal of Food Science. 1989; 54: 1557-1558), usando como sustrato el R-naftil caprilato. La determinación de la actividad amilasa se realizó de acuerdo a Vega-Villasante et al. , (Vega-Villasante, F. et al. Bulletin of Marine Science, 1999; 65: 1-9), usando como sustrato almidón al 1 % en TRIS-HCL (50 mM, pH 8.0). La actividad quimiotripsina fue evaluada de acuerdo a Delmar E.G. et al. (Delmar E.G. et ai. Anal Biochem. 1979; 99:318-320. La actividad específica de cada enzima está representada en unidades de enzima por miligramo de proteína (U/mg). For the analysis of the digestive enzymatic activity, the protease, lipase, amylase and chymotrypsinase activity was determined in the enzymatic extracts prepared by the methodology proposed by Galgani F. (Galgani, F. PhD. Thesis Université dÁix-Marseille //. Etude des digestive proteases of crevettes peneides (Crustacean Pickled) France. 1983) in hepatopancreas extracted from shrimp, at the indicated intervals previously and that were stored, for said analysis, at a temperature of - 48 ° C. In addition, the concentration of proteins present in said enzymatic extracts was determined by the Bradford method. The method described by Hernández CM (Hernández, CM Crustacean protease characterization biochemical and molecular consideration. Comprehensive summary Ph D Thesis. 1983. Northwest Biological Research Center, La Paz, was followed to obtain the protease activity data present in the enzyme extracts. BCS Mexico.), Using azocasein as substrate. The lipase activity present in the extracts was determined according to Versaw WK et al. (Versaw, WK et al. Journal of Food Science. 1989; 54: 1557-1558), using R-naphthyl caprylate as substrate. Amylase activity was determined according to Vega-Villasante et al. , (Vega-Villasante, F. et al. Bulletin of Marine Science, 1999; 65: 1-9), using as a substrate 1% starch in TRIS-HCL (50 mM, pH 8.0). The chemotrypsin activity was evaluated according to Delmar EG et al. (Delmar EG et ai. Anal Biochem. 1979; 99: 318-320. The specific activity of each enzyme is represented in units of enzyme per milligram of protein (U / mg).
Los resultados obtenidos pusieron de manifiesto que, la adición de los aditivos descritos en la invención a la dieta del camarón L. vannamei, incrementaron la actividad enzimática digestiva, presentando una mayor expresión de las enzimas digestivas analizadas (Figura 7) respecto a los camarones alimentados con la dieta control. Los camarones que recibieron el aditivo ECOBIOL SÚPER mostraron una mayor evidencia en la actividad específica de las enzimas lipasas y quimiotripsina (lípidos y proteínas). The results obtained showed that, the addition of the additives described in the invention to the diet of shrimp L. vannamei, increased digestive enzymatic activity, presenting a greater expression of the digestive enzymes analyzed (Figure 7) with respect to fed shrimp With the control diet. Shrimp that received the additive ECOBIOL SUPER showed greater evidence on the specific activity of the enzymes lipases and chymotrypsin (lipids and proteins).
Se concluye que los aditivos descritos en la presente invención utilizados en las dietas para animales acuáticos, preferentemente crustáceos y particularmente, la combinación de los probióticos CECT 5940+CECT 953+butirato sódico (BP-70), favorecen la actividad específica de las enzimas digestivas y el factor de conversión en el alimento de los crustáceos lo cual sugiere un mayor aprovechamiento del alimento, así como un incremento en su biomasa y supervivencia, respecto a animales alimentados con una dieta control, no suplementada con los aditivos de la invención. Ejemplo 3. Estudio in vitro de la capacidad de liberación de bacteriocinas del aditivo de la invención B. amyloliquefaciens CECT 5940 y análisis de su actividad biocida frente a organismos patógenos. Las bacteriocinas son péptidos microbianos de reducido tamaño y que son liberadas extracelularmente. Dichos péptidos tienen un efecto bactericida o bacteriostático sobre otras especies bacterianas. El objetivo de este estudio fue evaluar la capacidad de producción de bacteriocinas del aditivo de la invención, B. amyloliquefaciens CECT 5940 (ECOBIOL). It is concluded that the additives described in the present invention used in diets for aquatic animals, preferably crustaceans and particularly, the combination of probiotics CECT 5940 + CECT 953 + sodium butyrate (BP-70), favor the specific activity of digestive enzymes and the conversion factor in the food of the crustaceans which suggests a greater use of the food, as well as an increase in its biomass and survival, with respect to animals fed a control diet, not supplemented with the additives of the invention. Example 3. In vitro study of the bacteriocin release capacity of the additive of the invention B. amyloliquefaciens CECT 5940 and analysis of its biocidal activity against pathogenic organisms. Bacteriocins are small microbial peptides that are released extracellularly. Such peptides have a bactericidal or bacteriostatic effect on other bacterial species. The objective of this study was to evaluate the bacteriocin production capacity of the additive of the invention, B. amyloliquefaciens CECT 5940 (ECOBIOL).
Para analizar la capacidad de producción de bacteriocinas por parte del aditivo de la invención B. amyloliquefaciens CECT 5940, dichas cepas son crecidas en un matraz con 50 mi de medio TSB (Bioser) durante 24 horas y con él se inoculan 2 matraces con 50 mi de medio TSB en proporción 1 : 100 que se mantienen en agitación a 200 rpm y 30°C durante 48 horas. To analyze the capacity of bacteriocins production by the additive of the invention B. amyloliquefaciens CECT 5940, said strains are grown in a flask with 50 ml of TSB medium (Bioser) for 24 hours and 2 flasks are inoculated with 50 ml of TSB medium in a 1: 100 ratio that is kept under stirring at 200 rpm and 30 ° C for 48 hours.
De estos matraces se toman muestras a las 7, 24 y 48 horas de cultivo. Se eliminan las células de los cultivos por centrifugación durante 20 minutos a 4000 rpm . De los sobrenadantes de las distintas muestras recogidas una parte fue neutralizada a pH 6.2 con HCI 5M y la otra se mantuvo con el pH original de la muestra tomada y que se muestra en la Tabla 2, con el fin de simular las condiciones fisiológicas en el intestino proximal y distal. Ambas fracciones fueron esterilizadas a través de un filtro de 0.22 μηι. Estas preparaciones fueron almacenadas a -20°C hasta su uso. La actividad biocida de los sobrenadantes previamente mencionados, se determinó por el método de difusión en placas (Cintas, L.M. et al. (1995). Applied & Environmental Microbiology. 61 : 2643-2648), sembradas con microorganismos patógenos de diferentes géneros. Cabe mencionar que todos los microorganismos utilizados en la presente invención, bien se disponía de muestras de los mismos o se han obtenidos de la Colección Española de Cultivos Tipo (CECT), sita en el Parque Científico de la Universidad de Valencia. Calle Catedrático Agustín Escardino, 9 de Paterna (Valencia). 3.1 Actividad biocida del aditivo de la invención ECOBIOL (B. amyloliciuefaciens CECT 5940) frente a organismos del género Clostridium Spp. Samples are taken from these flasks at 7, 24 and 48 hours of culture. The cells are removed from the cultures by centrifugation for 20 minutes at 4000 rpm. Of the supernatants of the different samples collected, one part was neutralized at pH 6.2 with 5M HCI and the other was maintained at the original pH of the sample taken and shown in Table 2, in order to simulate the physiological conditions in the proximal and distal intestine. Both fractions were sterilized through a 0.22 μηι filter. These preparations were stored at -20 ° C until use. The biocidal activity of the above-mentioned supernatants was determined by the plate diffusion method (Tapes, LM et al. (1995). Applied & Environmental Microbiology. 61: 2643-2648), seeded with pathogenic microorganisms of different genera. It should be mentioned that all the microorganisms used in the present invention, either samples of them were available or were obtained from the Spanish Type Culture Collection (CECT), located in the Scientific Park of the University of Valencia. Calle Agustín Escardino Professor, 9 of Paterna (Valencia). 3.1 Biocidal activity of the additive of the invention ECOBIOL (B. amyloliciuefaciens CECT 5940) against organisms of the genus Clostridium Spp.
Todas las cepas de Clostridia se cultivaron en medio de agar-clostridium a una concentración aproximada de 106 UFC/placa. A excepción de B. amyloliquefaciens CECT 5940, que se cultivó a 30 °C, el resto de las cepas se incubaron a 37 °C en ausencia de oxígeno, en el interior de frascos de anaerobiosis. All strains of Clostridia were grown in agar-clostridium medium at an approximate concentration of 10 6 CFU / plaque. With the exception of B. amyloliquefaciens CECT 5940, which was grown at 30 ° C, the rest of the strains were incubated at 37 ° C in the absence of oxygen, inside anaerobiosis bottles.
Las siguientes cepas de Clostridium se utilizaron como indicadores de la existencia de bacteriocinas.  The following strains of Clostridium were used as indicators of the existence of bacteriocins.
Clostridium butyricum CECT 361 T Clostridium butyricum CECT 361 T
Clostridium perfringens CECT 376T Clostridium perfringens CECT 376T
Clostridium perfringens CECT 486 Clostridium perfringens CECT 486
Clostridium perfringens CECT 820 Clostridium perfringens CECT 820
Clostridium perfringens C ECT 821 Clostridium perfringens C ECT 821
Clostridium perfringens CECT 822 Clostridium perfringens CECT 822
Clostridium histolyticum CECT 4109T Clostridium histolyticum CECT 4109T
50 μΙ de cada sobrenadante del cultivo de B. amyloliquefaciens CECT 5940 (ECOBIOL) se depositaron en los pocilios (6mm de diámetro) de placas de Nutrient Agar (BioKar, pH 7± 0.2) suplementado con 3% v/v de NaCI, previamente sembradas con 200 de un cultivo que se había mantenido en crecimiento toda la noche de los microorganismos patógenos a ensayar frente a los que se pretende probar la producción de bacteriocinas. Como control se emplea el medio TSB. 50 μΙ of each culture supernatant of B. amyloliquefaciens CECT 5940 (ECOBIOL) were deposited in the wells (6mm in diameter) of Nutrient Agar plates (BioKar, pH 7 ± 0.2) supplemented with 3% v / v NaCI, previously planted with 200 of a culture that had been growing overnight of the pathogenic microorganisms to be tested against those intended to test the production of bacteriocins. The TSB medium is used as control.
Tras 2 horas a 4°C para permitir la difusión del producto en el medio, las placas se incuban a las temperaturas correspondientes para cada uno de los microorganismos patógenos, para permitir el crecimiento del organismo diana. Tras 24 horas, se determina la presencia o ausencia de un halo de inhibición del crecimiento. Todos los muéstreos se realizaron por duplicado, tanto en la recogida de sobrenadantes, como en la siembra de placas. After 2 hours at 4 ° C to allow diffusion of the product in the medium, the plates are incubated at the corresponding temperatures for each of the pathogenic microorganisms, to allow the growth of the target organism. After 24 hours, the presence or absence of a growth inhibition halo is determined. All sampling was done in duplicate, both in the collection of supernatants, and in the sowing of plates.
La actividad biocida de los sobrenadantes de cultivos de B. amyloliquefaciens CECT 5940 contra diferentes cepas bacterianas del género Clostridium patógenas, se muestran en la Tabla 2. Tabla 2. Efecto biocida in vitro de los sobrenadantes aislados de cultivos de B. amyloliquefaciens CECT 5940 frente a diferentes cepas bacterianas del género Clostridium. The biocidal activity of the supernatants of cultures of B. amyloliquefaciens CECT 5940 against different bacterial strains of the pathogenic Clostridium genus, are shown in Table 2. Table 2. Biocidal effect in vitro of the supernatants isolated from cultures of B. amyloliquefaciens CECT 5940 against different bacterial strains of the genus Clostridium.
Figure imgf000026_0001
Figure imgf000026_0001
+: Inhibición del crecimiento; -: no inhibición del crecimiento;  +: Growth inhibition; -: no growth inhibition;
Los datos mostrados en la Tabla 2 se explican como sigue: (cm de halo de inhibición) +: 1 cm de halo de inhibición The data shown in Table 2 is explained as follows: (cm of inhibition halo) +: 1 cm of inhibition halo
+ +: 1 ,5 cm de halo de inhibición  + +: 1.5 cm of inhibition halo
+ + +: 1 ,8 cm de halo de inhibición  + + +: 1.8 cm inhibition halo
+ + + +: 2,2 cm de halo de inhibición  + + + +: 2.2 cm of inhibition halo
-: Ausencia de halo de inhibición  -: Absence of inhibition halo
Los sobrenadantes aislados de cultivos de B. amyloliquefaciens CECT 5940 inhibieron el crecimiento de la mayoría de cepas del género Clostridium analizadas (Tabla 2). En este sentido, los resultados mostrados en la Tabla 2 ponen de manifiesto que B. amyloliquefaciens CECT 5940 muestra una gran capacidad para liberar bacteriocinas durante las primeras 24 horas. Es conveniente comentar que, las cepas de la especie Clostridium butyricum CECT 361 T presentan un crecimiento poco homogéneo en relación al resto de las cepas, por lo que resulta difícil la determinación de su halo de inhibición. 3.2. Actividad biocida del aditivo de la invención ECOBIOL (B. amyloliciuefaciens CECT 5940) frente a organismos patógenos hemolíticos y enterotóxicos. Supernatants isolated from cultures of B. amyloliquefaciens CECT 5940 inhibited the growth of most strains of the Clostridium genus analyzed (Table 2). In this sense, the results shown in Table 2 show that B. amyloliquefaciens CECT 5940 shows a great capacity to release bacteriocins during the first 24 hours. It is convenient to comment that, the strains of the species Clostridium butyricum CECT 361 T have a slightly homogeneous growth in relation to the rest of the strains, so it is difficult to determine their inhibition halo. 3.2. Biocidal activity of the additive of the invention ECOBIOL (B. amyloliciuefaciens CECT 5940) against hemolytic and enterotoxic pathogens.
La concentración de bacterias patógenas 106 U FC/placa se inoculó con el medio adecuado. Varias muescas de un tamaño de 6 mm de diámetro se hicieron en las placas de cultivos de los microorganismos patógenos y el sobrenadante de B. amyloliquefaciens CECT 5940 se introdujo en cada uno (50 μΙ). Las placas se incubaron a 4 °C durante 2 horas para dejar que los diferentes componentes del sobrenadante difundan hacia el medio de cultivo de la placa. Después de eso, todas las placas se incubaron a 37 °C durante 24 horas y se procedió a determinar el halo de inhibición para así poner de manifiesto el efecto bactericida. The concentration of pathogenic bacteria 10 6 U FC / plaque was inoculated with the appropriate medium. Several notches of a size of 6 mm in diameter were made in the culture plates of the pathogenic microorganisms and the supernatant of B. amyloliquefaciens CECT 5940 was introduced in each (50 μΙ). The plates were incubated at 4 ° C for 2 hours to allow the different components of the supernatant to diffuse into the plate culture medium. After that, all plates were incubated at 37 ° C for 24 hours and the inhibition halo was determined in order to demonstrate the bactericidal effect.
Las cepas patógenas evaluadas fueron: The pathogenic strains evaluated were:
Enterococcus faecalis CECT 4176 Enterococcus faecalis CECT 4176
Enterococcus gallinarum CECT 970 Enterococcus gallinarum CECT 970
Escherichia coli CECT 352  Escherichia coli CECT 352
Escherichia coli CECT 434  Escherichia coli CECT 434
Escherichia coli CECT 504  Escherichia coli CECT 504
Escherichia coli CECT 728  Escherichia coli CECT 728
Escherichia coli CECT 735 Escherichia coli CECT 735
Escherichia coli CECT 742  Escherichia coli CECT 742
Escherichia coli CECT 816  Escherichia coli CECT 816
Escherichia coli CECT 4076  Escherichia coli CECT 4076
Escherichia coli CECT 4267  Escherichia coli CECT 4267
Escherichia coli CECT 4782 Escherichia coli CECT 4782
Escherichia coli CECT 4783  Escherichia coli CECT 4783
Staphylococcus aureus CECT 957  Staphylococcus aureus CECT 957
Yersinia enterocolitica CECT 754 Todas las cepas de E. coli se seleccionaron de acuerdo con el fenotipo (0:147 H:7). El resto son cepas patógenas conocidas según la CECT (Colección Española de Cultivos Tipo), excepto Enterococcus, las cuales fueron seleccionadas como cepas bacterianas ácido lácticas (LAB). Yersinia enterocolitica CECT 754 All strains of E. coli were selected according to the phenotype (0: 147 H: 7). The rest are pathogenic strains known according to the CECT (Spanish Crop Collection Type), except Enterococcus, which were selected as lactic acid bacterial strains (LAB).
Los resultados obtenidos se muestran en la Tabla 3. The results obtained are shown in Table 3.
Tabla 3. Efecto bactericida in vitro del aditivo de la invención ECOBIOL (β. amyloliquefaciens CECT 5940) frente a diferentes bacterias patógenas. Table 3. In vitro bactericidal effect of the additive of the invention ECOBIOL (β. Amyloliquefaciens CECT 5940) against different pathogenic bacteria.
Figure imgf000028_0001
Figure imgf000028_0001
Los resultados ponen de manifiesto que las cepas de E. coli patógenas, además de Yersinia, se inhiben con el sobrenadante del aditivo ECOBIOL (β. amyloliquefaciens CECT 5940). The results show that pathogenic E. coli strains, in addition to Yersinia, are inhibited with the additive supernatant ECOBIOL (β. Amyloliquefaciens CECT 5940).
Está plenamente demostrado que las cepas patógenas ven inhibido su crecimiento por las bacteriocinas incluso a pH elevado, teniendo por tanto las bacteriocinas un amplio espectro de acción. Las bacteriocinas no mostraron interacciones positivas con LAB, los efectos sólo son acusados por las bacterias patógenas. It is fully demonstrated that pathogenic strains are inhibited by bacteriocins growth even at high pH, thus having a broad spectrum of action. Bacteriocins did not show positive interactions with LAB, the effects are only accused by pathogenic bacteria.
3.3 Actividad biocida del aditivo de la invención ECOBIOL (B. amyloliciuefaciens CECT 5940) frente a organismos patógenos del género Vibrio. 3.3 Biocidal activity of the additive of the invention ECOBIOL (B. amyloliciuefaciens CECT 5940) against pathogenic organisms of the Vibrio genus.
Las bacterias del género Vibrio son bacterias Gram-negativas encontradas comúnmente en estuarios y aguas marinas, por lo general en climas templados y tropicales. Algunas especies, como por ejemplo, la especie V. parahaemolyticus, pueden causar gastroenteritis en humanos. Huéspedes naturales de V. parahemolyticus incluyen cangrejos, camarones, tortugas, ostras, langostas y peces. La especie V. gastroenteritis es a menudo asociada con la infección en camarones. Vibrio genus bacteria are Gram-negative bacteria commonly found in estuaries and marine waters, usually in temperate and tropical climates. Some species, such as the V. parahaemolyticus species, can cause gastroenteritis in humans. Natural guests of V. parahemolyticus include crabs, shrimp, turtles, oysters, lobsters and fish. The species V. gastroenteritis is often associated with infection in shrimp.
Estudio recientes han relacionado al patógeno V. parahemolyticus con la EMS también conocida como AHPNS (acute hepatopancreatic necrosis síndrome) patología causante de altas mortalidades de los camarones que ha producido ya pérdidas del orden de 1.000 millones de dólares en el sudeste de Asia. Un estudio realizado por Donald Lightner (Universidad de Arizona) ha encontrado que esta bacteria infectada por un fago produce una toxina que afecta al órgano digestivo del camarón, el hepatopáncreas produciendo la muerte de la práctica totalidad de los animales cultivados a edades muy tempranas. Recent studies have linked the pathogen V. parahemolyticus to the EMS also known as AHPNS (acute hepatopancreatic necrosis syndrome), a pathology that causes high mortality of shrimp that has already produced losses of around 1 billion dollars in Southeast Asia. A study by Donald Lightner (University of Arizona) has found that this bacterium infected by a phage produces a toxin that affects the digestive organ of shrimp, the hepatopancreas causing the death of almost all animals grown at very early ages.
Para demostrar el efecto bactericida del aditivo de la invención ECOBIOL (β. amyloliquefaciens CECT 5940) sobre las bacterias del género Vibrio, particularmente sobre las especies V. parahaemolyticus CECT 51 1 y V. harveyi CECT 525, se utilizó la técnica del halo de inhibición. Brevemente, después del cultivo del aditivo que comprende B. amyloliquefaciens CECT 5940 (ECOBIOL), extractos libres de células de B. amyloliquefaciens se obtuvieron por centrifugación y se usaron para probar el efecto bactericida de dicho sobrenadante sobre las cepas de Vibrio arriba mencionadas, mediante la técnica de halo de inhibición. To demonstrate the bactericidal effect of the additive of the invention ECOBIOL (β. Amyloliquefaciens CECT 5940) on the bacteria of the genus Vibrio, particularly on the species V. parahaemolyticus CECT 51 1 and V. harveyi CECT 525, the inhibition halo technique was used . Briefly, after cultivation of the additive comprising B. amyloliquefaciens CECT 5940 (ECOBIOL), cell-free extracts of B. amyloliquefaciens were obtained by centrifugation and used to test the bactericidal effect of said supernatant on the aforementioned Vibrio strains, by the halo inhibition technique.
Las dos cepas fueron crecidas en medio Nutrient Broth (Biokar) suplementado con un 3% v/v de NaCI, e incubadas en agitador orbital a las temperaturas recomendadas en cada caso por la CECT durante 16 horas. Los resultados ponen de manifiesto que los sobrenadantes obtenidos de los cultivos de ECOBIOL (β. amyloliquefaciens CECT 5940), según se ha descrito previamente, mostraron halos de inhibición alrededor de las trazas realizadas sobre cultivos de la especie patógena V. parahemolyticus CECT 511, pero no, frente a los cultivos de V. harveyi CECT 525. Además, los resultados indican que la cepa V. parahaemolyticus CECT 511 , que presenta halo para todos los sobrenadantes recogidos, dichos halos de inhibición son más evidentes tras 24 horas de incubación. Por lo tanto, el sobrenadante de B. amyloliquefaciens CECT 5940 (ECOBIOL) contiene algún compuesto, tipo bacteriocina, que inhibe el crecimiento de Vibrio parahaemolyticus CECT 511. Los números que aparecen en la Tabla 4 indican el diámetro del halo de inhibición en milímetros correspondientes a cada uno de los sobrenadantes ensayados (ha de tenerse en cuenta que el pocilio en el que se aplica la muestra tiene un diámetro de 6 mm que se incluye también en el tamaño del halo). The two strains were grown in Nutrient Broth medium (Biokar) supplemented with 3% v / v NaCI, and incubated in an orbital shaker at the temperatures recommended in each case by the CECT for 16 hours. The results show that the supernatants obtained from the cultures of ECOBIOL (β. Amyloliquefaciens CECT 5940), as previously described, showed halos of inhibition around the traces made on cultures of the pathogenic species V. parahemolyticus CECT 511, but not, against the cultures of V. harveyi CECT 525. In addition, the results indicate that the strain V. parahaemolyticus CECT 511, which It has halo for all collected supernatants, such inhibition halos are more evident after 24 hours of incubation. Therefore, the supernatant of B. amyloliquefaciens CECT 5940 (ECOBIOL) contains some compound, bacteriocin type, that inhibits the growth of Vibrio parahaemolyticus CECT 511. The numbers shown in Table 4 indicate the diameter of the inhibition halo in corresponding millimeters to each of the supernatants tested (it should be noted that the well in which the sample is applied has a diameter of 6 mm which is also included in the size of the halo).
La capacidad demostrada de B. amyloliquefaciens CECT 5940 para inhibir el crecimiento de este patógeno, podría ayudar frente al control de la EMS. The demonstrated ability of B. amyloliquefaciens CECT 5940 to inhibit the growth of this pathogen could help with the control of EMS.
Tabla 4. Efecto bactericida in vitro de B. amyloliquefaciens CECT 5940 (ECOBIOL) frente a las bacterias patógenas V. parahaemolyticus Table 4. In vitro bactericidal effect of B. amyloliquefaciens CECT 5940 (ECOBIOL) against pathogenic bacteria V. parahaemolyticus
Figure imgf000030_0001
Figure imgf000030_0001
3.4 Actividad biocida del aditivo ECOBIOL (B. amyloliquefaciens CECT 5940) frente a organismos patógenos de las especies Aeromonas salmonicida y Yersinia ruckeri. 3.4 Biocidal activity of the additive ECOBIOL (B. amyloliquefaciens CECT 5940) against pathogenic organisms of the species Aeromonas salmonicida and Yersinia ruckeri.
B. amyloliquefaciens CECT 5940 se incubó en medio TSA, que se ajustó a los pH de 5 y 8, con el fin de simular las condiciones fisiológicas en el intestino proximal y distal. Además, se evaluaron dos diferentes condiciones de salinidad (0,5 y 3%). Los ensayos de actividad (halo de inhibición) se llevaron a cabo en MHA-1 (Mueller-Hilton agar a 1 % de NaCI), en el que se inocularon los agentes patógenos y se colocaron los discos empapados con el probiótico. Los resultados se expresaron como inhibición (+) o falta de inhibición (-). B. amyloliquefaciens CECT 5940 was incubated in TSA medium, which was adjusted to pH 5 and 8, in order to simulate physiological conditions in the proximal and distal intestine. In addition, two different salinity conditions (0.5 and 3%) were evaluated. The essays of activity (halo inhibition) were carried out in MHA-1 (Mueller-Hilton agar at 1% NaCl), in which the pathogens were inoculated and the soaked discs were placed with the probiotic. The results were expressed as inhibition (+) or lack of inhibition (-).
Los resultados se muestran a continuación: The results are shown below:
Tabla 5. Efecto bactericida in vitro de B. amyloliquefaciens CECT 5940 (ECOBIOL) frente a las bacterias patógenas A.salmonicida y Y.ruckeri. Table 5. In vitro bactericidal effect of B. amyloliquefaciens CECT 5940 (ECOBIOL) against the pathogenic bacteria A.salmonicida and Y.ruckeri.
Figure imgf000031_0001
Figure imgf000031_0001
Los resultados (Tabla 5) ponen de manifiesto que a pH 5 y 8, así como en condiciones de alta salinidad, B. amyloliquefaciens CECT 5940 (ECOBIOL) presenta actividad inhibidora frente a bacterias patógenas que afectan al salmón y la trucha (A. salmonicida y Y. ruckeri). The results (Table 5) show that at pH 5 and 8, as well as in high salinity conditions, B. amyloliquefaciens CECT 5940 (ECOBIOL) exhibits inhibitory activity against pathogenic bacteria that affect salmon and trout (A. salmonicida and Y. ruckeri).
Ejemplo 4. Capacidad de producción de ácidos orgánicos por B. amyloliquefaciens CECT 5940 en condiciones de anaerobiosis. Example 4. Production capacity of organic acids by B. amyloliquefaciens CECT 5940 under anaerobic conditions.
El objetivo del presente ejemplo es evaluar la capacidad de producción de ácido láctico del aditivo de la invención ECOBIOL (β. amyloliquefaciens CECT 5940) en condiciones de anaerobiosis autogeneradas. Una vez que B. amyloliquefaciens CECT 5940 llega al intestino y comienza a crecer, la producción de ácido láctico excretado al lumen del intestino provoca una acidificación del medio que resulta en un crecimiento preferencial de la flora acidófila, teniendo ésta un efecto beneficioso sobre la salud intestinal. El crecimiento preferencial de este tipo de microorganismos desplaza a las bacterias patógenas mediante el conocido mecanismo de exclusión competitiva. Por todo lo anterior el estado sanitario del animal experimenta un fortalecimiento. Las condiciones de crecimiento y de cultivo de las cepas de B. amyloliquefaciens CECT 5940 ya se han descrito a lo largo del presente documento. La composición del medio experimental es la siguiente: The objective of the present example is to evaluate the production capacity of lactic acid of the additive of the invention ECOBIOL (β. Amyloliquefaciens CECT 5940) under self-generated anaerobiosis conditions. Once B. amyloliquefaciens CECT 5940 reaches the intestine and begins to grow, the production of lactic acid excreted to the lumen of the intestine causes acidification of the medium resulting in a preferential growth of the acidophilic flora, having a beneficial effect on health intestinal. The preferential growth of this type of microorganisms displaces the pathogenic bacteria through the known mechanism of competitive exclusion. For all the above, the sanitary state of the animal experiences a strengthening. The growth and culture conditions of the strains of B. amyloliquefaciens CECT 5940 have already been described throughout this document. The composition of the experimental medium is as follows:
Semillas de soja micronizada 4%  4% micronized soybeans
Jarabe de glucosa 1 % (equivalente a 5, 1 g/L de azúcares reductores)  1% glucose syrup (equivalent to 5.1 g / L of reducing sugars)
Extracto de levadura 1 %  1% yeast extract
La composición del medio descrito arriba imita la proporción de proteínas y carbohidratos en el lumen intestinal de los animales. The composition of the medium described above mimics the proportion of proteins and carbohydrates in the intestinal lumen of the animals.
Cultivos experimentales se llevaron a cabo en botellas de 200 mi cerradas, para evitar la transferencia de oxígeno al medio de cultivo. El oxígeno disuelto inicialmente en el medio de cultivo, medido por sonda, era de aproximadamente un 0%, ya que fue eliminado en el proceso de esterilización anterior a la inoculación. Trazas de oxígeno disponible también se eliminaron en las primeras fases de crecimiento de microorganismos, por lo tanto, se crearon las condiciones de anaerobiosis autogenerados (igual que el lumen intestinal de los animales). Las condiciones de cultivo fueron: cultivos estáticos a 37 °C durante 24 horas. Los siguientes parámetros fueron evaluados en las muestras obtenidas a lo largo de la fermentación: Experimental cultures were carried out in closed 200 ml bottles, to avoid the transfer of oxygen to the culture medium. The oxygen initially dissolved in the culture medium, measured by probe, was approximately 0%, since it was eliminated in the sterilization process prior to inoculation. Traces of available oxygen were also eliminated in the early stages of microorganism growth, therefore, the conditions of self-generated anaerobiosis (same as the animal's intestinal lumen) were created. The culture conditions were: static cultures at 37 ° C for 24 hours. The following parameters were evaluated in the samples obtained throughout the fermentation:
1. CFU/ml: De acuerdo con la técnica de dilución de suero y posterior recuento de colonias en el medio de cultivo adecuado de B. amyloliquefaciens CECT 5940. 2. La producción de ácido láctico: Los m étod os uti l i zad o s f u e ro n espectofotométricos, y la determinación de la presencia de NADH a una absorbancia de A340 en muestras de extracto de fermentación centrifugados y libre de células, con los sistemas enzimáticos Boehringer Mannheim. 1. CFU / ml: According to the technique of serum dilution and subsequent colony counting in the appropriate culture medium of B. amyloliquefaciens CECT 5940. 2. Lactic acid production: The methods used in the process. n spectophotometric, and the determination of the presence of NADH at an absorbance of A340 in centrifugal and cell-free fermentation extract samples, with the Boehringer Mannheim enzyme systems.
3. Producción de ácido acético: El método utilizado fue espectofotométrico y la determinación de la presencia de NADH a A340 en muestras de extractos de fermentación centrifugados y libre de células, con sistemas enzimáticos Boehringer Mannheim.  3. Acetic acid production: The method used was spectophotometric and the determination of the presence of NADH at A340 in samples of centrifugal and cell-free fermentation extracts, with Boehringer Mannheim enzymatic systems.
4. Reductor de consumo de azúcares: El método utilizado fue colorimétrico, con el DNS reactiva, para establecer la cantidad residual de azúcares reductores en medios de cultivo de fermentación centrifugados. Para el cálculo de la tasa de producción de ácido se utilizaron fórmulas apropiadas: 4. Reducer of sugar consumption: The method used was colorimetric, with the reactive DNS, to establish the residual amount of reducing sugars in centrifuged fermentation culture media. Appropriate formulas were used to calculate the acid production rate:
Rendimiento (Y) = gramos de ácido/gramos de azúcar reductor consumido Tasa de producción de ácido (R) = gramos de ácido/109 UFC biomasa x hora Yield (Y) = grams of acid / grams of reducing sugar consumed Acid production rate (R) = grams of acid / 10 9 CFU biomass per hour
Los resultados pusieron de manifiesto la producción de ácido por parte de las cepas de B. amyloliquefaciens CECT 5940 en las condiciones de anaerobiosis autogenerados. The results showed the acid production by the strains of B. amyloliquefaciens CECT 5940 under the conditions of self-generated anaerobiosis.
Tabla 6. Producción de ácido por parte de cultivos de B. amyloliquefaciens CECT 5940 en condiciones de anaerobiosis. Table 6. Acid production by cultures of B. amyloliquefaciens CECT 5940 under anaerobic conditions.
Figure imgf000033_0001
Figure imgf000033_0001
La mayor parte de la producción de ácido por el metabolismo fermentativo de B. amyloliquefaciens CECT 5940 da lugar a ácido L-láctico, pero también es capaz de producir ácido acético. La capacidad de conversión de ácidos regulados por el pH intestinal es muy alta. Se puede lograr la misma masa de ácidos que las bacterias asimiladoras de azúcares. Tales ácidos se pueden utilizar como controladores de pH en el intestino (bio-control de patógenos) y/o como fuente de carbono y energía disponible. Además, el azúcar no convertido en ácido es utilizado como biomasa para el crecimiento de los microorganismos. Esta demostrada capacidad de producción de ácido láctico, ejerce un efecto de modulación de la flora bacteriana intestinal, beneficiando el crecimiento de las especies favorables e inhibiendo el crecimiento de patógenos que pudieran crecer produciendo infecciones. Most of the acid production by the fermentative metabolism of B. amyloliquefaciens CECT 5940 results in L-lactic acid, but is also capable of producing acetic acid. The ability to convert acids regulated by intestinal pH is very high. The same mass of acids as the sugar assimilating bacteria can be achieved. Such acids can be used as pH controllers in the intestine (bio-control of pathogens) and / or as a source of carbon and available energy. In addition, sugar not converted to acid is used as biomass for the growth of microorganisms. This demonstrated ability to produce lactic acid exerts an effect of modulation of the intestinal bacterial flora, benefiting the growth of favorable species and inhibiting the growth of pathogens that could grow causing infections.
Ejemplo 5. Respuesta del crecimiento, morfología intestinal, hematología y composición corporal de la Tilapia de Nilo (Oreochromis niloticus (L.)) alimentada con dieta estándar suplementada con los aditivos de la invención. En el presente ejemplo se evalúa el uso del aditivo de la invención ECOBIOL (β. amyloliquefaciens CECT 5940) como probiótico en la tilapia del Nilo. Un total de 120 O. niloticus (L.) alevines (peso promedio de 9.4 ± 0.3 g) se dividieron en 3 grupos (20 peces/grupo) por duplicado. El grupo denominado G1 fue alimentado con una dieta basal como el grupo de control; mientras que los grupos denominados G2 y G3 fueron alimentados con la dieta basal a la que se le añadió el aditivo ECOBIOL (β. amyloliquefaciens CECT 5940) en los niveles finales a una concentración de esporas del mismo de 1x109 y 1x107 u.f.c./kg, respectivamente. Example 5. Growth response, intestinal morphology, hematology and body composition of Nile Tilapia (Oreochromis niloticus (L.)) fed a standard diet supplemented with the additives of the invention. In the present example, the use of the additive of the invention ECOBIOL (β. Amyloliquefaciens CECT 5940) as a probiotic in Nile tilapia is evaluated. A total of 120 O. niloticus (L.) fry (average weight of 9.4 ± 0.3 g) They were divided into 3 groups (20 fish / group) in duplicate. The group called G1 was fed a basal diet as the control group; while the groups called G2 and G3 were fed the basal diet to which the additive ECOBIOL (β. amyloliquefaciens CECT 5940) was added in the final levels at a spore concentration of 1x10 9 and 1x10 7 cfu / kg respectively.
Después de 30 días de alimentación, el grupo G2 mostró aumentos significativos en el peso corporal final (FBW, final body weight en sus siglas en inglés) (Figura 8), en el aumento de peso (WG, weight gain, en sus siglas en inglés) (Figura 8) y la tasa de crecimiento específico (SGR, specific growth rate, en sus siglas en inglés) (Figura 8) en comparación con los grupos G1 y G3. Al final del período de alimentación, los grupos G2 y G3 tuvieron aumentos significativos en FBW, WG, SGR (Figura 8A y B) y en la relación de eficacia proteínica (PER, protein efficacy ratio, en sus siglas en inglés) e n comparación con el grupo control (G1) (Figura 8C). After 30 days of feeding, the G2 group showed significant increases in final body weight (FBW) (Figure 8), in weight gain (WG). English) (Figure 8) and the specific growth rate (SGR) (Figure 8) compared to groups G1 and G3. At the end of the feeding period, groups G2 and G3 had significant increases in FBW, WG, SGR (Figure 8A and B) and in the protein efficacy ratio (PER) compared to the control group (G1) (Figure 8C).
Además, el uso de una mayor concentración de probiótico en la dieta de los animales aumentó la altura de las vellosidades intestinales, especialmente en la parte proximal del intestino. Así, el grupo G2, presentó un número significativamente mayor de células secretoras de moco (células caliciformes), en las partes proximal y distal del intestino, que los grupos G3 o G1 (Figura 9A-E). In addition, the use of a higher concentration of probiotics in the animals' diet increased the height of the intestinal villi, especially in the proximal part of the intestine. Thus, the G2 group presented a significantly higher number of mucus-secreting cells (goblet cells), in the proximal and distal parts of the intestine, than the G3 or G1 groups (Figure 9A-E).
Los resultados obtenidos, también pusieron de manifiesto que los animales del grupo G2 presentaban una mayor concentración significativa de linfocitos intra-epiteliales (IEL, intra-epithelial lymphocytes, en sus siglas en inglés) en el intestino en comparación con el grupo control G1 , en todas las partes de los intestinos, mientras que el grupo G3 presentaba significativamente más lELs que el grupo control G1 , pero sólo en la parte distal del intestino (Figura 9F). The results obtained also showed that the animals of the G2 group had a higher significant concentration of intra-epithelial lymphocytes (IEL) in the intestine compared to the control group G1, in all parts of the intestines, while the G3 group had significantly more LELs than the G1 control group, but only in the distal part of the intestine (Figure 9F).
La adición a la dieta de la tilapia del Nilo del aditivo ECOBIOL (β. amyloliquefaciens CECT 5940) no tuvo efectos nocivos sobre el recuento total de eritrocitos ni sobre los niveles de glucosa, pero sí que incrementó el contenido de hemoglobina, los valores del hematocrito y el recuento total de leucocitos (Figura 10). The addition to the diet of the Nile tilapia of the additive ECOBIOL (β. Amyloliquefaciens CECT 5940) had no harmful effects on the total red blood cell count or glucose levels, but it did increase the hemoglobin content, hematocrit values and the total white blood cell count (Figure 10).
La adición de alta concentración de B. amyloliquefaciens CECT 5940 en la dieta de la tilapia del Nilo (grupo G2) produjo mejores efectos que una menor concentración de dicho aditivo (grupo G3) sobre la concentración total de proteínas en suero y sobre los niveles de globulina. El contenido de proteínas en todo el cuerpo de los animales incluidos en los grupos G2 y G3 fueron superiores a los niveles de proteínas encontrados en el grupo control (G1). La mayor concentración de grasa se registró en el grupo G2, seguido del grupo G3 y a continuación el grupo G1 (Figura 11). The addition of high concentration of B. amyloliquefaciens CECT 5940 in the diet of Nile tilapia (group G2) produced better effects than a lower concentration of said additive (group G3) on the total serum protein concentration and on the levels of globulin The protein content throughout the body of the animals included in groups G2 and G3 were higher than the levels of proteins found in the control group (G1). The highest fat concentration was recorded in group G2, followed by group G3 and then group G1 (Figure 11).
En otros experimentos realizados en tilapias cultivadas en presencia de la cepa patógena A. hydrofila, se observó que los animales que recibieron el aditivo de la invención ECOBIOL (β. amyloliquefaciens CECT 5940) en la dieta presentaron mayor actividad lisozima (enzima con actividad antibacteriana) en sangre (p<0.05) y un incremento numérico en el recuento de glóbulos blancos. Estos parámetros indican una mejor predisposición a resistir infecciones. In other experiments performed in tilapia grown in the presence of the pathogenic strain A. hydrofila, it was observed that the animals that received the additive of the invention ECOBIOL (β. Amyloliquefaciens CECT 5940) in the diet had higher lysozyme activity (enzyme with antibacterial activity) in blood (p <0.05) and a numerical increase in white blood cell count. These parameters indicate a better predisposition to resist infections.
Estos resultados ponen de manifiesto, por tanto, que la adición del aditivo ECOBIOL (β. amyloliquefaciens CECT 5940) a la dieta de la tilapia del Nilo (O. niloticus), muestra un efecto beneficioso sobre dichos animales, tanto en la potenciación de su crecimiento, como de su sistema inmune (inmunoestimulador). These results show, therefore, that the addition of the additive ECOBIOL (β. Amyloliquefaciens CECT 5940) to the diet of Nile tilapia (O. niloticus), shows a beneficial effect on these animals, both in the potentiation of their growth, as of your immune system (immunostimulator).
Ejemplo 6. Evaluación del aditivo de la invención ECOBIOL (B. amyloliquefaciens CECT 5940) y de Gustor BP-70 como promotores de crecimiento en dietas con harina de pescado o torta de soya para alevines de trucha arco iris (Oncorhynchus mykiss). Example 6. Evaluation of the additive of the invention ECOBIOL (B. amyloliquefaciens CECT 5940) and Gustor BP-70 as growth promoters in diets with fishmeal or soy cake for rainbow trout fry (Oncorhynchus mykiss).
El objetivo del presente ejemplo es evaluar la adición a una dieta de alevines de trucha arco iris (O. mykiss), dos promotores de crecimiento, ECOBIOL (β. amyloliquefaciens CECT 5940) y Gustor BP-70, solos o combinados, en el nivel de 0.1 %, en dietas a base de harina de pescado o de torta de soya, sobre el comportamiento productivo, tomando en cuenta los parámetros de crecimiento (ganancia de peso y talla), conversión de alimento y supervivencia de dichos animales. Se utilizaron las facilidades de las instalaciones del Centro de Producción Piscícola de Vinchos, situado en el distrito de Canchayllo, perteneciente a la SAIS "Tupac Amaru", en el departamento de Junín (Perú). La elaboración de las dietas experimentales se realizó en la Planta de Alimentos Balanceados del Programa de Investigación y Proyección Social en Alimentos, Facultad de Zootecnia, de la Universidad Nacional Agraria La Molina (Lima, Perú), durante los meses de marzo, abril y mayo del 2012, con una duración de 60 días. The objective of the present example is to evaluate the addition to a diet of rainbow trout fry (O. mykiss), two growth promoters, ECOBIOL (β. Amyloliquefaciens CECT 5940) and Gustor BP-70, alone or in combination, at the level 0.1%, in diets based on fishmeal or soy cake, on the productive behavior, taking into account the parameters of growth (weight gain and height), food conversion and survival of these animals. The facilities of the Vinchos Fish Production Center, located in the district of Canchayllo, belonging to the SAIS "Tupac Amaru", in the department of Junín (Peru) were used. The experimental diets were prepared at the Balanced Food Plant of the Social Research and Projection Program in Food, School of Zootechnics, of the National Agrarian University La Molina (Lima, Peru), during the months of March, April and May of 2012, with a duration of 60 days.
Se instalaron 170000 alevines de trucha arco iris en 30 estanques de 5 x 0.60 metros (unidades experimentales), con capacidad para 5000 peces cada uno. Se realizaron tres ingresos, en periodos de 15 días (réplicas); el primero con peces con peso promedio de 2.2 g y 6.0 cm de talla; a los 15 días se instalaron peces con un peso promedio 0.15 g y 2.25 cm de talla y a los siguientes 15 días, peces con un peso promedio de 0.08 g y 1.90 cm de talla. Se formularon dos dietas comerciales, una de ellas a base a harina de pescado (43%) y otra a base a torta de soya (50%), se utilizó la programación lineal a mínimo coste, según las recomendaciones del NRC (1993). A cada dieta experimental se le añadieron 0.1 % de170000 rainbow trout fry were installed in 30 ponds of 5 x 0.60 meters (experimental units), with capacity for 5000 fish each. Three entries were made, in periods of 15 days (replicas); the first with fish with an average weight of 2.2 g and 6.0 cm in size; after 15 days, fish with an average weight of 0.15 g and 2.25 cm in size were installed and after 15 days, fish with an average weight of 0.08 g and 1.90 cm in size. Two commercial diets were formulated, one based on fishmeal (43%) and one based on soybean cake (50%), linear programming was used at minimum cost, according to the recommendations of the NRC (1993). To each experimental diet 0.1% of
ECOBIOL (β. amyloliquefaciens CECT 5940) o BP-70 o la mezcla de ambos, dando lugar a 8 tratamientos. Cada uno de los tratamientos comprende: ECOBIOL (β. Amyloliquefaciens CECT 5940) or BP-70 or the mixture of both, giving rise to 8 treatments. Each of the treatments includes:
T1 : 43% de harina de pescado (HP) y 25 % de torta de soya (TS) T1: 43% fishmeal (HP) and 25% soy cake (TS)
T2: 29 % de HP y 50% de TS  T2: 29% HP and 50% TS
T3: HP+ECOBIOL  T3: HP + ECOBIOL
T4: TS+ECOBIOL  T4: TS + ECOBIOL
T5: HP+BP-70  T5: HP + BP-70
T6: TS+BP-70 T6: TS + BP-70
T7: HP+ECOBIOL+BP-70  T7: HP + ECOBIOL + BP-70
T8: TS+ ECOBIOL+BP-70  T8: TS + ECOBIOL + BP-70
Los datos de los resultados fueron sometidos a un análisis estadístico, considerando el Diseño de Bloques Completamente al Azar (DBCA), con la finalidad de expresar las diferencias entre los tratamientos, mediante el análisis de variancia (ANVA) y diferencias de los promedios en los parámetros evaluados utilizando la prueba estadística de DUNCAN . En la Tabla 7 se muestra la composición del alimento utilizado y su valor nutritivo. Tabla 7. Fórmulas usadas en las dietas experimentales y su valor nutritivo. The data of the results were subjected to a statistical analysis, considering the Design of Blocks Completely Random (DBCA), with the purpose of expressing the differences between the treatments, by means of the analysis of variance (ANVA) and differences of the averages in the parameters evaluated using the DUNCAN statistical test. Table 7 shows the composition of the food used and its nutritional value. Table 7. Formulas used in experimental diets and their nutritional value.
Dieta Basal Harina Dieta Basal TortaBasal Diet Flour Basal Diet Cake
Ingredientes (%) de Pescado de Soya Ingredients (%) of Soy Fish
Harina de pecado prime 43.00 29.00Prime Flour 43.00 29.00
Harinilla de trigo 30.10 15.10Wheat flour 30.10 15.10
Torta de soya, 47 25.00 50.00Soy cake, 47 25.00 50.00
Aceite vegetal 1.00 3.00Vegetable oil 1.00 3.00
Aceite semi refinado de pescado 1.92Semi refined fish oil 1.92
Sal 0.58 0.66Salt 0.58 0.66
Premezcla de vitaminas y minerales 0.30 0.30Vitamin and mineral premix 0.30 0.30
Antioxidante 0.02 0.02 Antioxidant 0.02 0.02
Total 100.00 100.00 Total 100.00 100.00
Valor Nutricional Calculado Calculated Nutritional Value
Proteína total, % 45.27 45.00 Total protein,% 45.27 45.00
Fibra, % 2.81 2.78Fiber,% 2.81 2.78
Grasa, % 7.84 9.60Fat,% 7.84 9.60
ED. Truchas, Mcal/kg 3.70 3.70ED. Trout, Mcal / kg 3.70 3.70
Lisina, % 3.20 3.15Lysine,% 3.20 3.15
Metionina, % 1.08 0.95Methionine,% 1.08 0.95
Cistina, % 0.51 0.59Cystine,% 0.51 0.59
Arginina, % 2.87 3.11Arginine,% 2.87 3.11
Histidina, % 1.12 1.14Histidine,% 1.12 1.14
Leucina, % 3.40 3.45Leucine,% 3.40 3.45
Isoleucina, % 2.10 2.10Isoleucine,% 2.10 2.10
Fenialanina, % 2.02 2.14Phenialanine,% 2.02 2.14
Tirosina, % 1.53 1.60Tyrosine,% 1.53 1.60
Treonina, % 1.85 1.85Threonine,% 1.85 1.85
Triptófano, % 0.55 0.59Tryptophan,% 0.55 0.59
Valina, % 2.37 2.41Valine,% 2.37 2.41
Met+Cist, % 1.59 1.53Met + Cist,% 1.59 1.53
Fen-tir, % 3.53 3.72Fen-tir,% 3.53 3.72
Ac Gr n-3, % 1.79 1.97 Dieta Basal Harina Dieta Basal TortaAc Gr n-3,% 1.79 1.97 Basal Diet Flour Basal Diet Cake
Ingredientes (%) de Pescado de Soya Ingredients (%) of Soy Fish
Ac Gr n-6, % 0.62 1.61  Ac Gr n-6,% 0.62 1.61
Fósforo total, % 1.49 1.17  Total match,% 1.49 1.17
Calcio, % 1.71 1.24  Calcium,% 1.71 1.24
Sodio, % 0.70 0.60  Sodium,% 0.70 0.60
Potasio, % 1.26 1.50  Potassium,% 1.26 1.50
Cloro, % 0.75 0.72  Chlorine,% 0.75 0.72
Colina, ppm 2957.75 2846.29  Hill, ppm 2957.75 2846.29
Prot Dig, % 41.80 42.43  Prot Dig,% 41.80 42.43
6.1 Resultados del peso y de la talla de O. mykiss alimentados con las dietas descritas en la Tabla 7 ¡unto con los aditivos de la invención. 6.1 Results of the weight and size of O. mykiss fed with the diets described in Table 7 together with the additives of the invention.
Los resultados de los parámetros de comportamiento productivo, cuyos valores corresponden al promedio de tres replicas, se muestra en las Figuras 12 a 16. Los peces alimentados con las dietas conteniendo mayor porcentaje de harina de pescado como fuente principal de proteína, mostraron mayor crecimiento en peso y talla comparado con aquellos que recibieron las dietas conteniendo torta de soya, en un 5.34 y 4.77%, respectivamente; experimentando mayor diferencia los peces de menor tamaño. The results of the parameters of productive behavior, whose values correspond to the average of three replicates, are shown in Figures 12 to 16. Fish fed with diets containing a higher percentage of fishmeal as the main source of protein, showed greater growth in weight and size compared to those who received diets containing soy cake, at 5.34 and 4.77%, respectively; experiencing smaller difference smaller fish.
La adición de los aditivos ECOBIOL (B. amyloliquefaciens CECT 5940) o BP-70 o la mezcla de ambos a las dietas con harina de pescado o torta de soya, no mejoraron estadísticamente la ganancia de peso y la talla (Figuras 12 y 13). Sin embargo, se observa una tendencia numérica a un mayor incremento de la talla con las dietas basadas en torta de soya con la adición de ECOBIOL (B. amyloliquefaciens CECT 5940) o BP-70. Por otro lado, la adición de ECOBIOL (B. amyloliquefaciens CECT 5940) a la dieta con torta de soya generó mayor crecimiento del peso y de la talla en los peces más pequeños, un 10 y un 16% respectivamente en relación a la dieta control sin ECOBIOL (B. amyloliquefaciens CECT 5940) (Figuras 12 y 13). 6.2. Resultados del consumo de alimento y de la conversión alimenticia de O.mykiss alimentados con las dietas descritas en la Tabla 7 ¡unto con los aditivos de la invención. The addition of the additives ECOBIOL (B. amyloliquefaciens CECT 5940) or BP-70 or the mixture of both to the diets with fishmeal or soy cake, did not statistically improve weight gain and height (Figures 12 and 13) . However, there is a numerical trend towards a greater increase in size with diets based on soy cake with the addition of ECOBIOL (B. amyloliquefaciens CECT 5940) or BP-70. On the other hand, the addition of ECOBIOL (B. amyloliquefaciens CECT 5940) to the diet with soy cake generated greater growth of weight and size in smaller fish, 10 and 16% respectively in relation to the control diet without ECOBIOL (B. amyloliquefaciens CECT 5940) (Figures 12 and 13). 6.2. Results of food consumption and food conversion of O.mykiss fed with the diets described in Table 7 together with the additives of the invention.
Los resultados indican que no existen diferencias estadísticas en el consumo de alimentos. Sin embargo, los peces alimentados con las dietas conteniendo harina de pescado, mostraron tendencia a mayor consumo de alimento (Figura 14). The results indicate that there are no statistical differences in food consumption. However, fish fed with diets containing fishmeal showed a tendency to higher feed consumption (Figure 14).
En relación a la conversión alimenticia, los peces que recibieron las dietas conteniendo harina de pescado, mostraron mejor conversión del alimento por unidad de ganancia de peso, siendo estadísticamente diferente a los peces que recibieron las dietas con torta de soya. La adición de ECOBIOL (β. amyloliquefaciens CECT 5940) a la dieta a base de torta de soya, mejoró significativamente la utilización del alimento en el crecimiento de los peces, siendo más eficientes en un 4%, comparado con los peces que recibieron la dieta control de torta de soya (Figura 15). Similar comportamiento se observa en los peces de diferentes tamaños (réplicas). In relation to food conversion, the fish that received the diets containing fishmeal, showed better feed conversion per unit of weight gain, being statistically different from the fish that received the diets with soy cake. The addition of ECOBIOL (β. Amyloliquefaciens CECT 5940) to the diet based on soybean cake, significantly improved the utilization of the food in the growth of the fish, being more efficient in 4%, compared with the fish that received the diet soy cake control (Figure 15). Similar behavior is observed in fish of different sizes (replicas).
6.3. Resultados de supervivencia de O.mykiss alimentados con las dietas descritas en la Tabla 7 ¡unto con los aditivos de la invención. Los peces que recibieron BP-70 en la dieta a base de torta de soya, lograron menor mortalidad (2.6%), estadísticamente significativa comparado con aquellos que recibieron las dietas con harina de pescado (4 %), con o sin la adición de BP-70 o ECOBIOL (β. amyloliquefaciens CECT 5940) a la dieta con torta de soya (3.6%). La supervivencia de los peces fue muy similar en todos los tratamientos (Figura 16). 6.3. Survival results of O.mykiss fed the diets described in Table 7 together with the additives of the invention. Fish that received BP-70 in the diet based on soy cake, achieved lower mortality (2.6%), statistically significant compared to those who received diets with fishmeal (4%), with or without the addition of BP -70 or ECOBIOL (β. Amyloliquefaciens CECT 5940) to the diet with soy cake (3.6%). Fish survival was very similar in all treatments (Figure 16).
Los resultados obtenidos en el presente ejemplo, ponen de manifiesto que las dietas conteniendo harina de pescado produjeron mayor crecimiento en peso y talla de los alevines de truchas en relación a la dieta con torta de soya. Además, la adición de ECOBIOL (β. amyloliquefaciens CECT 5940) o BP-70 a las dietas conteniendo harina de pescado o torta de soya no mejoraron el crecimiento en relación al peso, aunque si se muestra una tendencia a un mayor crecimiento en talla en dietas con torta de soya. The results obtained in the present example show that the diets containing fishmeal produced greater growth in weight and size of trout fry in relation to the diet with soy cake. In addition, the addition of ECOBIOL (β. Amyloliquefaciens CECT 5940) or BP-70 to diets containing fishmeal or soy cake did not improve growth in relation to weight, although if there is a tendency to increase growth in size in Diets with soy cake.
La adición del aditivo ECOBIOL (β. amyloliquefaciens CECT 5940) a la dieta conteniendo torta de soya mejoró estadísticamente la conversión alimenticia, mientras que la adición de BP-70 a la dieta conteniendo torta de soya, redujo significativamente la mortalidad, logrando mayor supervivencia de los animales. Con los resultados mostrados, parece evidente la utilización de dietas a base a torta de soya como fuente de proteína más la adición de ECOBIOL (β. amyloliquefaciens CECT 5940) para reducir el coste de alimentación debido a un ahorro económico por la mayor eficiencia en las dietas para truchas. The addition of the additive ECOBIOL (β. Amyloliquefaciens CECT 5940) to the diet containing soy cake statistically improved food conversion, while the addition of BP-70 to the diet containing soy cake, significantly reduced mortality, achieving greater survival of animals. With the results shown, the use of diets based on soy cake as a source of protein plus the addition of ECOBIOL (β. Amyloliquefaciens CECT 5940) to reduce the cost of feeding due to economic savings due to greater efficiency in Trout diets
Ejemplo 7. Uso de ECOBIOL (B. amyloliquefaciens CECT 5940) como agente de biorremediación. Example 7. Use of ECOBIOL (B. amyloliquefaciens CECT 5940) as a bioremediation agent.
La calidad del agua y la gestión de la calidad del suelo es considerado como uno de los aspectos más importantes de la acuicultura en estanques. Si bien los parámetros de calidad del agua, tales como oxígeno disuelto, pH, o las concentraciones de amoníaco afectan a funciones esenciales del cuerpo, el estado del fondo de los estanques y el intercambio de sustancias entre el suelo y el agua afecta en gran medida la calidad del agua. La acumulación de residuos aumentará la demanda de oxígeno por parte de las bacterias con el fin de realizar su metabolismo y degradar la materia orgánica, favoreciendo el desarrollo de zonas anaeróbicas. Estos sedimentos anóxicos se pondrán en contacto con la columna de agua rica en oxígeno, produciendo una alteración de las condiciones ambientales adecuadas para un desarrollo saludable de los organismos que habitan en dichos estanques. Además, el amoníaco puede difundirse en la columna de agua no sólo como resultado de las excreciones de los peces, sino también después de la descomposición microbiana de la materia orgánica. En condiciones de alta temperatura y pH, la acumulación de amoníaco puede causar efectos sub-letales como retraso del crecimiento o la propensión a las enfermedades. Por lo tanto, es de importancia clave para mantener el fondo del estanque en condiciones aeróbicas y evitar que la materia orgánica y los limos se acumulen. En este sentido, Bacillus spp. son considerados como agentes de biorremediación, concepto que se refiere a la utilización de microorganismos que ayudan en el mantenimiento del ambiente del estanque adecuado gracias a la secreción de exo-enzimas que descomponen la materia orgánica. La finalidad del presente ejemplo es evaluar la capacidad in vitro de ECOBIOL (β. amyloliquefaciens CECT 5940) como agente de biorremediación. Water quality and soil quality management is considered one of the most important aspects of pond aquaculture. While water quality parameters, such as dissolved oxygen, pH, or ammonia concentrations affect essential functions of the body, the state of the bottom of the ponds and the exchange of substances between the soil and water greatly affects water quality The accumulation of waste will increase the demand for oxygen by bacteria in order to perform their metabolism and degrade organic matter, favoring the development of anaerobic areas. These anoxic sediments will be in contact with the oxygen-rich water column, producing an alteration of the environmental conditions suitable for a healthy development of the organisms that inhabit these ponds. In addition, ammonia can diffuse in the water column not only as a result of fish excretion, but also after microbial decomposition of organic matter. Under high temperature and pH conditions, the accumulation of ammonia can cause sub-lethal effects such as growth retardation or disease propensity. Therefore, it is of key importance to keep the bottom of the pond in aerobic conditions and prevent organic matter and silts from accumulating. In this sense, Bacillus spp. They are considered as bioremediation agents, a concept that refers to the use of microorganisms that help in maintaining the environment of the appropriate pond thanks to the secretion of exo-enzymes that break down organic matter. The purpose of the present example is to evaluate the in vitro capacity of ECOBIOL (β. Amyloliquefaciens CECT 5940) as a bioremediation agent.
En primer lugar se evaluó la demanda química de oxígeno (DQO), que se define como una medida de la capacidad del agua para consumir oxígeno durante la descomposición de la materia orgánica y la oxidación de los productos químicos inorgánicos, tales como el amoníaco y el nitrito. El agua se obtiene de un criadero de peces y se añadió en bandejas (300 cm2). La profundidad alcanzada por la capa de agua y lodo fue de 5 cm. ECOBIOL (β. amyloliquefaciens) y otras bacterias probióticas se añadieron en las bandejas de tratamiento y se evaluaron por duplicado de la siguiente manera: First, the chemical oxygen demand (COD) was evaluated, which is defined as a measure of the ability of water to consume oxygen during the decomposition of organic matter and the oxidation of inorganic chemicals, such as ammonia and nitrite. Water is obtained from a fish farm and added in trays (300 cm 2 ). The depth reached by the layer of water and mud was 5 cm. ECOBIOL (β. Amyloliquefaciens) and other probiotic bacteria were added in the treatment trays and evaluated in duplicate as follows:
Figure imgf000041_0001
Figure imgf000041_0001
Dos valores de DQO se determinaron: 1) soluble y 2) total. Two COD values were determined: 1) soluble and 2) total.
Las medidas de DQO solubles en el sobrenadante se realizaron después de transcurridos 15 min de sedimentación tras la homogeneización de los medios, mientras que las medidas de DQO totales se realizaron inmediatamente después de la homogeneización. Las mediciones se llevaron a cabo en el día 0 (inicial), el día 3 y el día 7. La temperatura se mantuvo a 25 °C. Los resultados revelaron que la DQO total se redujo progresivamente en los grupos de tratamiento, sobre todo en los tratados con ECOBIOL (β. amyloliquefaciens CECT 5940). Además, la capa de agua y lodo se redujo a 4 cm de profundidad. Esto indica unos niveles más bajos de residuos, y por consiguiente, mejores condiciones ambientales, debido a la acción biorremediadora del tratamiento con ECOBIOL (β. amyloliquefaciens CECT 5940) (Ver Tabla 8). The soluble COD measurements in the supernatant were made after 15 min of sedimentation after homogenization of the media, while the total COD measurements were made immediately after homogenization. The measurements were carried out on day 0 (initial), day 3 and day 7. The temperature was maintained at 25 ° C. The results revealed that the total COD was progressively reduced in the treatment groups, especially in those treated with ECOBIOL (β. Amyloliquefaciens CECT 5940). In addition, the layer of water and mud was reduced to 4 cm deep. This indicates lower levels of waste, and consequently, better environmental conditions, due to the bioremediation action of treatment with ECOBIOL (β. Amyloliquefaciens CECT 5940) (See Table 8).
De acuerdo con los resultados mostrados, el uso de ECOBIOL (B. amyloliquefaciens CECT 5940) como agente de biorremediación puede ayudar a mantener el ambiente del estanque adecuado favoreciendo así el crecimiento saludable de los organismos que viven en él. Tabla 8. Resultados de la demanda química de oxígeno (DQO) analizados a lo largo del tratamiento. According to the results shown, the use of ECOBIOL (B. amyloliquefaciens CECT 5940) as a bioremediation agent can help maintain the proper pond environment thus favoring the healthy growth of the organisms that live in it. Table 8. Results of the chemical oxygen demand (COD) analyzed throughout the treatment.
DQO mg02/L Inicial 3 días 7 días COD mg0 2 / L Initial 3 days 7 days
Variación Variation
Soluble Total Soluble Total Soluble Total Soluble Total Soluble Total Soluble Total
Control 89.0 1677.5 <30 1848.5 <30 1873.5 +10.43% Control 89.0 1677.5 <30 1848.5 <30 1873.5 + 10.43%
ECOBIOL 89.5 2145.5 <30 1602.0 <30 1559.0 -37.25%ECOBIOL 89.5 2145.5 <30 1602.0 <30 1559.0 -37.25%
B. cereus 86 2694.0 <30 2143.5 <30 2057.5 -30.85%B. cereus 86 2694.0 <30 2143.5 <30 2057.5 -30.85%
B. licheniformis 95.5 1692.5 <30 1678.5 <30 1653.5 -2.35% B. licheniformis 95.5 1692.5 <30 1678.5 <30 1653.5 -2.35%

Claims

REIVINDICACIONES
1. Uso de Bacillus amyloliquefaciens, en la cría de animales acuáticos. 2. Uso según la reivindicación 1 caracterizado por que en la cría de animales acuáticos se utiliza la cepa CECT 5940 de B. amyloliquefaciens. 1. Use of Bacillus amyloliquefaciens, in the breeding of aquatic animals. 2. Use according to claim 1 characterized in that the strain CECT 5940 of B. amyloliquefaciens is used in the breeding of aquatic animals.
3. Uso según cualquiera de las reivindicaciones 1 a 2 caracterizado por que en la cría de animales acuáticos se utiliza además al menos la especie Bacillus cereus. 3. Use according to any one of claims 1 to 2 characterized in that at least the Bacillus cereus species is also used in the breeding of aquatic animals.
4. Uso según la reivindicación 3 caracterizado por que en la cría de animales acuáticos se utiliza la cepa CECT 953 de B. cereus. 4. Use according to claim 3 characterized in that in the breeding of aquatic animals the strain CECT 953 of B. cereus is used.
5. Uso según cualquiera de las reivindicaciones 1 a 4 caracterizado por que en la cría de animales acuáticos se utiliza además al menos la especie Pediococcus acidilactici. 5. Use according to any one of claims 1 to 4 characterized in that at least the Pediococcus acidilactici species is also used in the breeding of aquatic animals.
6. Uso según la reivindicación 5 caracterizado por que en la cría de animales acuáticos se utiliza la cepa CNCM MA 18/5 M de P. acidilactici. 6. Use according to claim 5 characterized in that in the breeding of aquatic animals the strain CNCM MA 18/5 M of P. acidilactici is used.
7. Uso según cualquiera de las reivindicaciones 1 a 6 caracterizado por que en la cría de animales acuáticos se utiliza además al menos otras especies seleccionadas de entre cualquiera de las siguientes: B. subtilis y B. licheniformis. 8. Uso según cualquiera de las reivindicaciones 1 a 7 caracterizado por que en la cría de animales acuáticos se utiliza además al menos una sal de un ácido orgánico. 7. Use according to any of claims 1 to 6, characterized in that at least other species selected from any of the following are used in the breeding of aquatic animals: B. subtilis and B. licheniformis. 8. Use according to any one of claims 1 to 7 characterized in that at least one salt of an organic acid is used in the breeding of aquatic animals.
9. Uso según la reivindicación 8 caracterizado por que la sal del ácido orgánico se encuentra preferentemente en una proporción de entre un 30-70% en peso húmedo, siendo más preferible una proporción del 60%. 9. Use according to claim 8 characterized in that the organic acid salt is preferably in a proportion of between 30-70% by wet weight, a proportion of 60% being more preferable.
10. Uso según cualquiera de las reivindicaciones 8 o 9 caracterizado por que los ácidos orgánicos se seleccionan de entre cualquiera de los siguientes: butírico, propiónico, fórmico, láctico, cítrico, láurico, cúprico, caprílico, caproico o acético. 10. Use according to any of claims 8 or 9 characterized in that the organic acids are selected from any of the following: butyric, propionic, formic, lactic, citric, lauric, cupric, caprylic, caproic or acetic.
1 1. Uso según cualquiera de las reivindicaciones 8 a 10 caracterizado por que las sales de ácidos orgánicos se seleccionan de entre cualquiera de la lista: sódica, cálcica, cúprica o potásica. 1 1. Use according to any of claims 8 to 10 characterized in that the salts of organic acids are selected from any of the list: sodium, calcium, cupric or potassium.
12. Uso según las reivindicaciones 8 a 11 caracterizado por que la sal del ácido orgánico es la sal sódica del ácido butírico. 12. Use according to claims 8 to 11 characterized in that the organic acid salt is the sodium salt of butyric acid.
13. Uso según las reivindicaciones 8 a 12 caracterizado por que en la cría de animales acuáticos se utiliza una combinación de las cepas CECT 5940 de B. amyloliquefaciens y CECT 953 de B. cereus junto con sal sódica del ácido butírico. 13. Use according to claims 8 to 12 characterized in that a combination of the CECT 5940 strains of B. amyloliquefaciens and CECT 953 of B. cereus is used in the breeding of aquatic animals together with sodium salt of butyric acid.
14. Uso según cualquiera de las reivindicaciones 1-2 caracterizado por que además, es capaz de modular la respuesta inmune y ejercer un efecto bactericida frente a microorganismos patógenos. 14. Use according to any of claims 1-2 characterized in that it is also able to modulate the immune response and exert a bactericidal effect against pathogenic microorganisms.
15. Uso según cualquiera de las reivindicaciones 1 a 14 donde los animales acuáticos son preferentemente moluscos, crustáceos, tilapia, dorada, lubina y salmónidos. 15. Use according to any of claims 1 to 14 wherein the aquatic animals are preferably molluscs, crustaceans, tilapia, gilthead sea bass, sea bass and salmonids.
16. Aditivo para alimentación de animales acuáticos que comprende la combinación de, al menos, dos especies pertenecientes al género Bacillus, seleccionadas de entre: B. amyloliquefaciens y B. cereus. 16. Additive for feeding aquatic animals comprising the combination of at least two species belonging to the genus Bacillus, selected from: B. amyloliquefaciens and B. cereus.
17. Aditivo según la reivindicación 16 caracterizado por que comprende la combinación de, al menos, la cepa CECT 5940 de B. amyloliquefaciens y la cepa CECT 953 de B. cereus. 17. Additive according to claim 16 characterized in that it comprises the combination of at least the CECT 5940 strain of B. amyloliquefaciens and the CECT 953 strain of B. cereus.
18. Aditivo según cualquiera de las reivindicaciones 16 a 17 caracterizado por que además puede comprender la especie, P. acidilactici. 18. Additive according to any of claims 16 to 17 characterized in that it can also comprise the species, P. acidilactici.
Aditivo según la reivindicación 18 caracterizado por que comprende la cepa CNCM MA 18/5 M de P. acidilactici. Additive according to claim 18 characterized in that it comprises the CNCM MA 18/5 M strain of P. acidilactici.
20. Aditivo según las reivindicaciones 16 a 19 caracterizado por que además comprende al menos una sal de un ácido orgánico. 20. Additive according to claims 16 to 19 characterized in that it further comprises at least one salt of an organic acid.
21. Aditivo según la reivindicación 20 caracterizado porque la sal del ácido orgánico se encuentra preferentemente en una proporción de entre un 30-70% en peso húmedo, siendo más preferible una proporción del 60%. 21. Additive according to claim 20 characterized in that the organic acid salt is preferably in a proportion of between 30-70% by wet weight, a proportion of 60% being more preferable.
Aditivo según cualquiera de las reivindicaciones 20 a 21 caracterizado por que los ácidos orgánicos se seleccionan de entre cualquiera de los siguientes: butírico, propiónico, fórmico, láctico, cítrico, láurico, cúprico, caprílico, caproico o acético. Additive according to any of claims 20 to 21 characterized in that the organic acids are selected from any of the following: butyric, propionic, formic, lactic, citric, lauric, cupric, caprylic, caproic or acetic.
Aditivo según las reivindicaciones 20 a 22 caracterizado por que las sales de ácidos orgánicos se seleccionan de entre cualquiera de la lista: sódica, cálcica, cúprica o potásica. Additive according to claims 20 to 22 characterized in that the salts of organic acids are selected from any of the list: sodium, calcium, cupric or potassium.
24. Aditivo según las reivindicaciones 20 a 23 caracterizado por que la sal del ácido orgánico es la sal sódica del ácido butírico. 24. Additive according to claims 20 to 23 characterized in that the organic acid salt is the sodium salt of butyric acid.
25. Aditivo según las reivindicaciones 16 a 24 caracterizado por que comprende una combinación de las cepas CECT 5940 de B. amyloliquefaciens y CECT 953 de B. cereus junto con sal sódica del ácido butírico. 26. Aditivo según las reivindicaciones 16 a 25 caracterizado por que los animales acuáticos se seleccionan de entre cualquiera de la lista: moluscos, crustáceos, tilapia, dorada, lubina y salmónidos. 25. Additive according to claims 16 to 24 characterized in that it comprises a combination of the CECT 5940 strains of B. amyloliquefaciens and CECT 953 of B. cereus together with sodium salt of butyric acid. 26. Additive according to claims 16 to 25 characterized in that the aquatic animals are selected from any of the list: mollusks, crustaceans, tilapia, gilthead sea bass, sea bass and salmonids.
Uso de los aditivos de las reivindicaciones 16 a 26 en la cría de animales acuáticos. Use of the additives of claims 16 to 26 in the breeding of aquatic animals.
28. Uso de los aditivos según la reivindicación 27 caracterizados por que además actúan como moduladores de la respuesta inmune. 29. Uso de los aditivos según la reivindicación 27 caracterizados por que además presentan acción bactericidas frente a microorganismos patógenos. 28. Use of the additives according to claim 27 characterized in that they also act as modulators of the immune response. 29. Use of the additives according to claim 27 characterized in that they also have bactericidal action against pathogenic microorganisms.
30. Uso de los aditivos según la reivindicación 27 caracterizados por que además presentan acción biorremediadora. Uso de los aditivos según las reivindicaciones 27 a 30 caracterizado por que los animales acuáticos se seleccionan de entre cualquiera de la lista: moluscos, crustáceos, tilapia, dorada, lubina y salmónidos. 30. Use of the additives according to claim 27 characterized in that they also have bioremediating action. Use of the additives according to claims 27 to 30, characterized in that the aquatic animals are selected from any of the list: molluscs, crustaceans, tilapia, gilthead sea bass, sea bass and salmonids.
PCT/ES2013/070573 2012-08-01 2013-08-01 Additives for feeding aquatic animals, containing probiotics WO2014020226A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201231256A ES2447090B1 (en) 2012-08-01 2012-08-01 ADDITIVES FOR THE FEEDING OF AQUATIC ANIMALS CONTAINING PROBIOTICS.
ESP201231256 2012-08-01

Publications (1)

Publication Number Publication Date
WO2014020226A1 true WO2014020226A1 (en) 2014-02-06

Family

ID=50027323

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2013/070573 WO2014020226A1 (en) 2012-08-01 2013-08-01 Additives for feeding aquatic animals, containing probiotics

Country Status (2)

Country Link
ES (1) ES2447090B1 (en)
WO (1) WO2014020226A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016011511A1 (en) * 2014-07-25 2016-01-28 The University Of Queensland Bacillus amyloliquefaciens probiotic compositions, methods of production, and methods of use
WO2019206820A1 (en) * 2018-04-23 2019-10-31 Evonik Degussa Gmbh Synbiotic compositions
WO2020165057A1 (en) * 2019-02-11 2020-08-20 Evonik Operations Gmbh Compositions containing bacillaene producing bacteria or preparations thereof
CN112239736A (en) * 2020-09-18 2021-01-19 华中农业大学 Bacillus amyloliquefaciens, microbial inoculum, screening method and application
WO2021032975A1 (en) 2019-08-20 2021-02-25 Sporegen Limitd Formulations for prevention or reduction of c. difficile infections
RU2799354C2 (en) * 2018-04-23 2023-07-05 Эвоник Оперейшенс ГмбХ Synbiotic compositions

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3908651A1 (en) * 2019-01-10 2021-11-17 Evonik Operations GmbH Fermentation broths and their use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228337A1 (en) * 2003-06-24 2006-10-12 Institute Francais de Recherche Pour L-explotation de la mer Use of bacilli bacteria in order to produce a composition for the prevention of vertebral compression syndrome in salmonids
KR20090030661A (en) * 2007-09-20 2009-03-25 양승창 A feed additive for raising fishes, a feed composition, and a breeding method thereof
JP2010051247A (en) * 2008-08-28 2010-03-11 Kyushu Medical:Kk Biological control agent containing bacillus amyloliquefaciens having antibacterial activity against pathogenic bacterium and fungus as active ingredient
CN101773209A (en) * 2010-02-10 2010-07-14 浙江科盛饲料股份有限公司 Compound feed for shellfish

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228337A1 (en) * 2003-06-24 2006-10-12 Institute Francais de Recherche Pour L-explotation de la mer Use of bacilli bacteria in order to produce a composition for the prevention of vertebral compression syndrome in salmonids
KR20090030661A (en) * 2007-09-20 2009-03-25 양승창 A feed additive for raising fishes, a feed composition, and a breeding method thereof
JP2010051247A (en) * 2008-08-28 2010-03-11 Kyushu Medical:Kk Biological control agent containing bacillus amyloliquefaciens having antibacterial activity against pathogenic bacterium and fungus as active ingredient
CN101773209A (en) * 2010-02-10 2010-07-14 浙江科盛饲料股份有限公司 Compound feed for shellfish

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ESPORAFEED. NOREL., 16 September 2011 (2011-09-16), Retrieved from the Internet <URL:Http://www.norel.es/eng/esporafeed.acui.htm> [retrieved on 20131024] *
NUEZ-ORTIZ W. ET AL.: "An effective solution to optimise health status and nutrient utilisation.", INTERNATIONAL AQUAFEED., May 2011 (2011-05-01), Retrieved from the Internet <URL:http://www.docstoc.com/?docId=83646636&download=> [retrieved on 20131024] *
NUEZ-ORTIZ: "W. Ecobiol Aqua. A unique and highly effective single strain probiotic.", INTERNATIONAL AQUAFEED., November 2011 (2011-11-01), Retrieved from the Internet <URL:http://www.docstoc.com/?docId=103806272&download=1> [retrieved on 20131024] *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016011511A1 (en) * 2014-07-25 2016-01-28 The University Of Queensland Bacillus amyloliquefaciens probiotic compositions, methods of production, and methods of use
AU2015292271B2 (en) * 2014-07-25 2020-09-10 The University Of Queensland Bacillus amyloliquefaciens probiotic compositions, methods of production, and methods of use
WO2019206820A1 (en) * 2018-04-23 2019-10-31 Evonik Degussa Gmbh Synbiotic compositions
CN112041427A (en) * 2018-04-23 2020-12-04 赢创运营有限公司 Synbiotic composition
RU2799354C2 (en) * 2018-04-23 2023-07-05 Эвоник Оперейшенс ГмбХ Synbiotic compositions
CN112041427B (en) * 2018-04-23 2023-10-24 赢创运营有限公司 Synbiotic composition
WO2020165057A1 (en) * 2019-02-11 2020-08-20 Evonik Operations Gmbh Compositions containing bacillaene producing bacteria or preparations thereof
WO2021032975A1 (en) 2019-08-20 2021-02-25 Sporegen Limitd Formulations for prevention or reduction of c. difficile infections
CN112239736A (en) * 2020-09-18 2021-01-19 华中农业大学 Bacillus amyloliquefaciens, microbial inoculum, screening method and application
CN112239736B (en) * 2020-09-18 2022-08-23 华中农业大学 Bacillus amyloliquefaciens, microbial inoculum, screening method and application

Also Published As

Publication number Publication date
ES2447090A1 (en) 2014-03-11
ES2447090B1 (en) 2014-12-19

Similar Documents

Publication Publication Date Title
Elala et al. Eubiotic effect of a dietary acidifier (potassium diformate) on the health status of cultured Oreochromis niloticus
Ghosh et al. Dietary probiotic supplementation in growth and health of live‐bearing ornamental fishes
Gupta et al. Growth performance, feed utilization, digestive enzyme activity, innate immunity and protection against Vibrio harveyi of freshwater prawn, Macrobrachium rosenbergii fed diets supplemented with Bacillus coagulans
Dhert et al. Advancement of rotifer culture and manipulation techniques in Europe
Castex et al. Probiotic P. acidilactici application in shrimp Litopenaeus stylirostris culture subject to vibriosis in New Caledonia
Touraki et al. Evaluation of the probiotics Bacillus subtilis and Lactobacillus plantarum bioencapsulated in Artemia nauplii against vibriosis in European sea bass larvae (Dicentrarchus labrax, L.)
Yu et al. Effect of acute exposure to ammonia and BFT alterations on Rhynchocypris lagowski: Digestive enzyme, inflammation response, oxidative stress and immunological parameters
Soltan et al. Effect of probiotics and some spices as feed additives on the performance and behaviour of the Nile tilapia, Oreochromis niloticus
Daniel et al. Exogenous probiotics on biofloc based aquaculture: a review.
Kumar et al. Effect of dietary synbiotic on growth performance, body composition, digestive enzyme activity and gut microbiota in Cirrhinus mrigala (Ham.) fingerlings
Gram et al. Prospects of fish probiotics
WO2014020226A1 (en) Additives for feeding aquatic animals, containing probiotics
Saad et al. Growth response of the freshwater prawn, Macrobrachium rosenbergii (De Man), to diets having different levels of Biogen®
Fernandez et al. Effect of lactic acid bacteria administered orally on growth performance of Penaeus indicus (H. Milne Edwards) juveniles
Kolndadacha et al. The role of probiotics in aquaculture in Nigeria-a review
Can et al. The effects of different dosage of kefir with different durations on growth performances and antioxidant system in the blood and liver tissues of Çoruh trout (Salmo coruhensis)
Ahmadifard et al. Evaluation of the impacts of long-term enriched Artemia with Bacillus subtilis on growth performance, reproduction, intestinal microflora, and resistance to Aeromonas hydrophila of ornamental fish Poecilia latipinna
WO2017147130A2 (en) Direct fed microbial for prevention of shrimp disease
US10500236B2 (en) Bioactive animal feed
Yarahmadi et al. Zootechnical performance, immune response, and resistance to hypoxia stress and Vibrio harveyi infection in Pacific white shrimp (Litopeneaus vannamei) fed different fishmeal diets with and without addition of sodium butyrate
ONIANWAH et al. Microorganisms in sustainable aquaculture development
KR20080037457A (en) Compositions for addition to feed for fish comprising bacillus polyfermenticus, bacillus licheniformis and saccharomyces serevisiae
Sudha et al. Bacillus licheniformis as a probiotic bacterium for culture of the prawn Macrobrachium rosenbergii
Hassanien et al. Physiological and haematological responses of the Nile tilapia (Oreochromis niloticus) fed on diets supplemented with probiotics
Sinha et al. Probiotic effect of a live bacterial isolate in nutrition of an Indian major carp, rohu (Labeo rohita)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13824947

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13824947

Country of ref document: EP

Kind code of ref document: A1